| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.763 | 0.005 | 0.763 | Cholesterol antagonist | 0.637 0.014 DBMET03172 0.557 0.024 DBMET03173 0.596 0.019 DBMET03174 | ||
| 0.736 | 0.004 | 0.736 | Histamine release inhibitor | 0.546 0.017 DBMET03172 0.508 0.026 DBMET03173 0.541 0.018 DBMET03174 | ||
| 0.725 | 0.005 | 0.725 | Platelet aggregation inhibitor | 0.561 0.006 DBMET03172 0.287 0.039 DBMET03173 0.234 0.06 DBMET03174 | ||
| 0.691 | 0.009 | 0.691 | Antithrombotic | 0.462 0.035 DBMET03172 0.507 0.028 DBMET03173 0.517 0.027 DBMET03174 0.666 0.01 DBMET03175 0.633 0.013 DBMET03176 0.577 0.019 DBMET03177 | ||
| 0.658 | 0.009 | 0.69 | Vasodilator, peripheral | 0.651 0.01 DBMET03172 0.69 0.007 DBMET03173 0.664 0.009 DBMET03174 0.296 0.099 DBMET03175 0.316 0.089 DBMET03176 | DBMET03173 | |
| 0.648 | 0.008 | 0.76 | Immunomodulator | 0.495 0.024 DBMET03172 0.33 0.067 DBMET03173 0.55 0.017 DBMET03174 0.76 0.005 DBMET03175 0.713 0.005 DBMET03176 0.741 0.005 DBMET03177 | DBMET03175 | |
| 0.637 | 0.005 | 0.76 | Platelet antagonist | 0.76 0.004 DBMET03172 0.573 0.008 DBMET03173 0.485 0.015 DBMET03174 0.316 0.048 DBMET03175 0.279 0.06 DBMET03176 0.264 0.066 DBMET03177 | DBMET03172 | |
| 0.623 | 0.012 | 0.791 | 5 Hydroxytryptamine release stimulant | 0.706 0.007 DBMET03172 0.791 0.004 DBMET03173 0.767 0.004 DBMET03174 | DBMET03173 | |
| 0.608 | 0.006 | 0.931 | Hypolipemic | 0.78 0.004 DBMET03172 0.931 0.003 DBMET03173 0.879 0.003 DBMET03174 | DBMET03173 | |
| 0.586 | 0.021 | 0.805 | Aldehyde oxidase inhibitor | 0.638 0.014 DBMET03172 0.74 0.006 DBMET03173 0.805 0.004 DBMET03174 | DBMET03174 | |
| 0.566 | 0.004 | 0.566 | Phospholipase C inhibitor | 0.441 0.008 DBMET03172 0.285 0.02 DBMET03173 0.256 0.024 DBMET03174 0.364 0.013 DBMET03175 0.393 0.011 DBMET03176 0.219 0.034 DBMET03177 | ||
| 0.571 | 0.01 | 0.583 | Hypoglycemic | 0.511 0.014 DBMET03172 0.51 0.014 DBMET03173 0.583 0.009 DBMET03174 | DBMET03174 | |
| 0.611 | 0.051 | 0.611 | Antiinflammatory | 0.551 0.068 DBMET03172 0.332 0.187 DBMET03173 0.473 0.1 DBMET03174 | ||
| 0.585 | 0.038 | 0.763 | Caspase 9 stimulant | 0.763 0.016 DBMET03172 0.498 0.061 DBMET03173 0.514 0.054 DBMET03174 | DBMET03172 | |
| 0.551 | 0.006 | 0.551 | Interleukin agonist | 0.432 0.015 DBMET03172 0.464 0.012 DBMET03173 0.453 0.013 DBMET03174 | ||
| 0.552 | 0.014 | 0.572 | Apoptosis antagonist | 0.572 0.013 DBMET03172 0.561 0.014 DBMET03173 0.455 0.027 DBMET03174 0.374 0.046 DBMET03177 | DBMET03172 | |
| 0.544 | 0.008 | 0.544 | Psychostimulant | 0.504 0.01 DBMET03172 0.467 0.014 DBMET03173 0.4 0.022 DBMET03174 | ||
| 0.553 | 0.019 | 0.608 | 5 Hydroxytryptamine release inhibitor | 0.606 0.01 DBMET03172 0.577 0.014 DBMET03173 0.608 0.01 DBMET03174 | DBMET03174 | |
| 0.548 | 0.023 | 0.791 | Immunostimulant | 0.409 0.047 DBMET03172 0.438 0.039 DBMET03173 0.452 0.036 DBMET03174 0.779 0.005 DBMET03175 0.791 0.004 DBMET03176 0.786 0.004 DBMET03177 | DBMET03176 | |
| 0.527 | 0.004 | 0.527 | Protein kinase stimulant | 0.349 0.012 DBMET03172 0.224 0.034 DBMET03173 0.218 0.036 DBMET03174 | ||
| 0.53 | 0.02 | 0.53 | Spasmolytic | 0.361 0.049 DBMET03172 0.335 0.057 DBMET03173 0.394 0.041 DBMET03174 | ||
| 0.505 | 0.004 | 0.505 | Mediator release inhibitor | 0.207 0.014 DBMET03172 0.154 0.027 DBMET03173 0.148 0.029 DBMET03174 | ||
| 0.498 | 0.008 | 0.498 | Anesthetic general | 0.498 0.008 DBMET03172 0.348 0.024 DBMET03173 0.463 0.01 DBMET03174 | ||
| 0.516 | 0.029 | 0.521 | Immunosuppressant | 0.502 0.032 DBMET03172 0.472 0.041 DBMET03173 0.486 0.037 DBMET03174 0.515 0.029 DBMET03175 0.521 0.027 DBMET03176 0.509 0.03 DBMET03177 | DBMET03176 | |
| 0.492 | 0.005 | 0.812 | Alpha-N-acetylglucosaminidase inhibitor | 0.602 0.004 DBMET03172 0.784 0.002 DBMET03173 0.812 0.002 DBMET03174 | DBMET03174 | |
| 0.493 | 0.011 | 0.642 | RNA-directed DNA polymerase inhibitor | 0.361 0.023 DBMET03172 0.265 0.042 DBMET03173 0.309 0.03 DBMET03174 0.623 0.004 DBMET03175 0.623 0.004 DBMET03176 0.642 0.004 DBMET03177 | DBMET03177 | |
| 0.495 | 0.016 | 0.612 | Vasodilator, coronary | 0.436 0.026 DBMET03172 0.405 0.034 DBMET03173 0.443 0.024 DBMET03174 0.612 0.007 DBMET03175 0.471 0.02 DBMET03176 0.362 0.05 DBMET03177 | DBMET03175 | |
| 0.479 | 0.002 | 0.479 | Toll-Like receptor 2 antagonist | 0.26 0.008 DBMET03172 0.238 0.011 DBMET03173 0.216 0.017 DBMET03174 | ||
| 0.485 | 0.013 | 0.501 | Vasodilator | 0.498 0.012 DBMET03172 0.428 0.019 DBMET03173 0.482 0.013 DBMET03174 0.501 0.012 DBMET03175 0.367 0.029 DBMET03176 0.376 0.027 DBMET03177 | DBMET03175 | |
| 0.475 | 0.015 | 0.846 | DNA synthesis inhibitor | 0.356 0.029 DBMET03172 0.362 0.028 DBMET03173 0.356 0.029 DBMET03174 0.846 0.003 DBMET03175 0.842 0.003 DBMET03176 0.771 0.004 DBMET03177 | DBMET03175 | |
| 0.506 | 0.048 | 0.698 | Cyclophilin D inhibitor | 0.522 0.044 DBMET03172 0.597 0.028 DBMET03173 0.698 0.014 DBMET03174 | DBMET03174 | |
| 0.524 | 0.067 | 0.524 | Apoptosis agonist | 0.503 0.073 DBMET03172 0.283 0.185 DBMET03173 0.302 0.17 DBMET03174 0.292 0.178 DBMET03176 0.383 0.122 DBMET03177 | ||
| 0.459 | 0.009 | 0.459 | Non-steroidal antiinflammatory agent | 0.267 0.037 DBMET03172 0.28 0.033 DBMET03173 0.277 0.034 DBMET03174 | ||
| 0.444 | 0.004 | 0.444 | Phospholipase A2 inhibitor | 0.302 0.013 DBMET03172 0.211 0.037 DBMET03173 0.181 0.053 DBMET03174 | ||
| 0.457 | 0.018 | 0.457 | DNA damaging | 0.372 0.035 DBMET03172 0.234 0.09 DBMET03173 0.207 0.11 DBMET03174 | ||
| 0.442 | 0.005 | 0.61 | Aldehyde dehydrogenase inhibitor | 0.361 0.007 DBMET03172 0.233 0.021 DBMET03173 0.275 0.014 DBMET03174 0.531 0.004 DBMET03175 0.56 0.004 DBMET03176 0.61 0.004 DBMET03177 | DBMET03177 | |
| 0.463 | 0.037 | 0.641 | GABA C receptor rho-3 antagonist | 0.641 0.005 DBMET03172 0.486 0.03 DBMET03173 0.478 0.032 DBMET03174 | DBMET03172 | |
| 0.419 | 0.002 | 0.419 | Lysophosphatidic acid 2 receptor antagonist | 0.163 0.003 DBMET03172 0.059 0.007 DBMET03173 0.049 0.009 DBMET03174 | ||
| 0.417 | 0.005 | 0.514 | DNA polymerase I inhibitor | 0.325 0.009 DBMET03172 0.151 0.049 DBMET03173 0.147 0.051 DBMET03174 0.513 0.004 DBMET03175 0.514 0.004 DBMET03176 0.493 0.004 DBMET03177 | DBMET03176 | |
| 0.442 | 0.046 | 0.442 | Toll-Like receptor agonist | 0.243 0.155 DBMET03172 | ||
| 0.421 | 0.025 | 0.481 | Cardiotonic | 0.262 0.074 DBMET03172 0.348 0.04 DBMET03173 0.481 0.017 DBMET03174 0.259 0.076 DBMET03175 0.176 0.144 DBMET03177 | DBMET03174 | |
| 0.402 | 0.014 | 0.628 | 5 Hydroxytryptamine uptake stimulant | 0.628 0.002 DBMET03172 0.452 0.007 DBMET03173 0.44 0.008 DBMET03174 | DBMET03172 | |
| 0.397 | 0.013 | 0.454 | Hepatoprotectant | 0.363 0.017 DBMET03172 0.365 0.017 DBMET03173 0.454 0.009 DBMET03174 0.166 0.094 DBMET03175 0.146 0.114 DBMET03176 0.157 0.103 DBMET03177 | DBMET03174 | |
| 0.364 | 0.009 | 0.364 | Alkylator | 0.241 0.018 DBMET03172 0.175 0.035 DBMET03173 0.223 0.02 DBMET03174 0.136 0.054 DBMET03175 0.135 0.056 DBMET03176 0.125 0.063 DBMET03177 | ||
| 0.364 | 0.013 | 0.442 | Tyrosine 3 hydroxylase inhibitor | 0.442 0.005 DBMET03172 0.385 0.01 DBMET03173 0.381 0.01 DBMET03174 | DBMET03172 | |
| 0.357 | 0.009 | 0.364 | Gastrin inhibitor | 0.364 0.008 DBMET03172 0.303 0.031 DBMET03173 0.3 0.033 DBMET03174 | DBMET03172 | |
| 0.351 | 0.005 | 0.489 | Succinate dehydrogenase inhibitor | 0.489 0.003 DBMET03172 0.438 0.004 DBMET03173 0.426 0.004 DBMET03174 | DBMET03172 | |
| 0.358 | 0.018 | 0.387 | Platelet adhesion inhibitor | 0.387 0.013 DBMET03172 0.31 0.031 DBMET03173 0.241 0.052 DBMET03174 0.132 0.128 DBMET03176 | DBMET03172 | |
| 0.338 | 0.01 | 0.338 | Anesthetic local | 0.224 0.026 DBMET03172 0.194 0.034 DBMET03173 0.234 0.023 DBMET03174 | ||
| 0.332 | 0.005 | 0.332 | Catenin beta inhibitor | 0.207 0.027 DBMET03172 | ||
| 0.327 | 0.003 | 0.327 | Acetylcholine release stimulant | 0.185 0.005 DBMET03172 0.121 0.047 DBMET03173 0.113 0.06 DBMET03174 | ||
| 0.343 | 0.022 | 0.343 | P-glycoprotein inhibitor | 0.164 0.097 DBMET03172 0.284 0.032 DBMET03173 0.231 0.048 DBMET03174 | ||
| 0.352 | 0.032 | 0.394 | Angiogenesis stimulant | 0.394 0.023 DBMET03172 0.307 0.047 DBMET03173 0.257 0.067 DBMET03174 | DBMET03172 | |
| 0.323 | 0.012 | 0.395 | Insulin sensitizer | 0.318 0.013 DBMET03172 0.395 0.007 DBMET03173 0.382 0.007 DBMET03174 | DBMET03173 | |
| 0.316 | 0.006 | 0.988 | Adenylate kinase inhibitor | 0.374 0.004 DBMET03172 0.353 0.004 DBMET03173 0.353 0.004 DBMET03174 0.988 0 DBMET03175 0.979 0 DBMET03176 0.96 0 DBMET03177 | DBMET03175 | |
| 0.315 | 0.005 | 0.38 | Catalase inhibitor | 0.316 0.005 DBMET03172 0.348 0.005 DBMET03173 0.38 0.004 DBMET03174 | DBMET03174 | |
| 0.337 | 0.031 | 0.337 | Anticonvulsant | 0.229 0.066 DBMET03172 | ||
| 0.351 | 0.046 | 0.365 | Antioxidant | 0.339 0.049 DBMET03172 0.295 0.063 DBMET03173 0.365 0.042 DBMET03174 | DBMET03174 | |
| 0.346 | 0.047 | 0.462 | Interleukin 2 agonist | 0.462 0.013 DBMET03172 0.364 0.04 DBMET03173 0.357 0.042 DBMET03174 | DBMET03172 | |
| 0.308 | 0.009 | 0.308 | Cell adhesion inhibitor | 0.204 0.023 DBMET03172 0.101 0.088 DBMET03174 | ||
| 0.332 | 0.039 | 0.332 | Transcription factor STAT3 inhibitor | 0.238 0.093 DBMET03172 0.212 0.119 DBMET03174 | ||
| 0.313 | 0.02 | 0.551 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.357 0.011 DBMET03172 0.284 0.029 DBMET03173 0.314 0.019 DBMET03174 0.551 0.003 DBMET03175 0.547 0.003 DBMET03176 0.454 0.005 DBMET03177 | DBMET03175 | |
| 0.298 | 0.007 | 0.298 | Toll-Like receptor antagonist | 0.158 0.05 DBMET03172 | ||
| 0.331 | 0.041 | 0.331 | Transcription factor STAT inhibitor | 0.221 0.111 DBMET03172 0.251 0.086 DBMET03174 | ||
| 0.306 | 0.017 | 0.306 | Monophenol monooxygenase inhibitor | 0.177 0.039 DBMET03172 0.123 0.059 DBMET03173 0.158 0.044 DBMET03174 | ||
| 0.326 | 0.044 | 0.578 | Tumour necrosis factor alpha release inhibitor | 0.287 0.058 DBMET03173 0.3 0.053 DBMET03174 0.578 0.008 DBMET03175 0.512 0.013 DBMET03176 0.371 0.033 DBMET03177 | DBMET03175 | |
| 0.329 | 0.055 | 0.4 | Sodium/bile acid cotransporter inhibitor | 0.4 0.017 DBMET03172 0.376 0.026 DBMET03173 0.373 0.027 DBMET03174 | DBMET03172 | |
| 0.281 | 0.008 | 0.281 | Antibacterial (Helicobacter pylori) | 0.219 0.018 DBMET03172 0.153 0.043 DBMET03173 0.225 0.016 DBMET03174 | ||
| 0.273 | 0.001 | 0.273 | Lysophosphatidic acid receptor 3 agonist | 0.081 0.002 DBMET03172 0.059 0.002 DBMET03173 0.052 0.002 DBMET03174 | ||
| 0.277 | 0.006 | 0.958 | Phosphofructokinase-1 inhibitor | 0.312 0.005 DBMET03172 0.371 0.004 DBMET03173 0.376 0.004 DBMET03174 0.958 0 DBMET03175 0.957 0 DBMET03176 0.942 0 DBMET03177 | DBMET03175 | |
| 0.269 | 0.001 | 0.269 | Lysophosphatidic acid 3 receptor antagonist | 0.136 0.003 DBMET03172 0.105 0.004 DBMET03173 0.098 0.005 DBMET03174 | ||
| 0.302 | 0.037 | 0.547 | Peroxidase inhibitor | 0.475 0.012 DBMET03172 0.545 0.006 DBMET03173 0.547 0.006 DBMET03174 | DBMET03174 | |
| 0.26 | 0.005 | 0.296 | Photosensitizer | 0.296 0.004 DBMET03172 0.153 0.029 DBMET03173 0.148 0.032 DBMET03174 | DBMET03172 | |
| 0.258 | 0.004 | 0.258 | Arachidonic acid antagonist | 0.255 0.005 DBMET03172 0.229 0.012 DBMET03173 0.231 0.011 DBMET03174 | ||
| 0.266 | 0.014 | 0.266 | Platelet activating factor antagonist | |||
| 0.259 | 0.012 | 0.259 | Interleukin 4 antagonist | 0.212 0.019 DBMET03172 0.109 0.102 DBMET03173 | ||
| 0.25 | 0.004 | 0.25 | Lanosterol 14 alpha demethylase inhibitor | 0.165 0.008 DBMET03172 0.124 0.026 DBMET03173 0.13 0.022 DBMET03174 | ||
| 0.282 | 0.036 | 0.449 | Growth hormone agonist | 0.449 0.01 DBMET03172 0.225 0.05 DBMET03173 0.283 0.036 DBMET03174 | DBMET03172 | |
| 0.252 | 0.007 | 0.674 | Glutamate dehydrogenase inhibitor | 0.278 0.006 DBMET03172 0.438 0.004 DBMET03173 0.484 0.003 DBMET03174 0.674 0.002 DBMET03175 0.621 0.002 DBMET03176 0.474 0.003 DBMET03177 | DBMET03175 | |
| 0.249 | 0.007 | 0.45 | Triose-phosphate isomerase inhibitor | 0.328 0.004 DBMET03172 0.411 0.003 DBMET03173 0.45 0.003 DBMET03174 | DBMET03174 | |
| 0.247 | 0.005 | 0.247 | Folate antagonist | 0.22 0.007 DBMET03172 0.097 0.071 DBMET03173 0.096 0.072 DBMET03174 0.092 0.083 DBMET03175 0.092 0.083 DBMET03176 | ||
| 0.249 | 0.009 | 0.249 | Cyclooxygenase 3 inhibitor | 0.217 0.014 DBMET03172 0.17 0.033 DBMET03173 0.188 0.023 DBMET03174 | ||
| 0.244 | 0.004 | 0.244 | Glutamate release inhibitor | 0.157 0.008 DBMET03172 0.173 0.006 DBMET03173 0.218 0.004 DBMET03174 | ||
| 0.264 | 0.026 | 0.309 | Interferon gamma antagonist | 0.295 0.021 DBMET03172 0.237 0.031 DBMET03173 0.309 0.019 DBMET03174 | DBMET03174 | |
| 0.274 | 0.037 | 0.274 | DNA methyltransferase I inhibitor | 0.23 0.055 DBMET03172 0.141 0.115 DBMET03173 0.16 0.094 DBMET03174 | ||
| 0.237 | 0.001 | 0.237 | Lysophosphatidic acid receptor 1 agonist | 0.084 0.002 DBMET03172 0.065 0.003 DBMET03173 0.068 0.003 DBMET03174 | ||
| 0.331 | 0.096 | 0.342 | Calpain 2 inhibitor | 0.342 0.091 DBMET03172 | DBMET03172 | |
| 0.239 | 0.005 | 0.239 | Toll-Like receptor 2 agonist | 0.16 0.01 DBMET03172 0.104 0.014 DBMET03173 0.126 0.013 DBMET03174 | ||
| 0.262 | 0.032 | 0.3 | Neurotrophic factor enhancer | 0.3 0.018 DBMET03172 0.256 0.035 DBMET03173 0.262 0.032 DBMET03174 | DBMET03172 | |
| 0.237 | 0.007 | 0.237 | Cell adhesion molecule inhibitor | 0.127 0.021 DBMET03172 | ||
| 0.256 | 0.028 | 0.256 | Melanin inhibitor | 0.231 0.032 DBMET03172 0.235 0.031 DBMET03173 0.203 0.039 DBMET03174 | ||
| 0.245 | 0.02 | 0.678 | Insulin secretagoues | 0.459 0.005 DBMET03172 0.385 0.007 DBMET03173 0.678 0.004 DBMET03174 | DBMET03174 | |
| 0.276 | 0.052 | 0.338 | Cyclic AMP phosphodiesterase inhibitor | 0.311 0.038 DBMET03172 0.215 0.083 DBMET03173 0.338 0.029 DBMET03174 | DBMET03174 | |
| 0.232 | 0.013 | 0.232 | Microtubule formation inhibitor | 0.178 0.026 DBMET03172 0.227 0.014 DBMET03173 0.221 0.016 DBMET03174 | ||
| 0.276 | 0.059 | 0.283 | Free radical scavenger | 0.283 0.056 DBMET03172 0.172 0.122 DBMET03173 0.236 0.075 DBMET03174 | DBMET03172 | |
| 0.225 | 0.008 | 0.225 | Gastric antisecretory | 0.186 0.015 DBMET03172 0.161 0.022 DBMET03173 0.119 0.043 DBMET03174 | ||
| 0.224 | 0.008 | 0.256 | Vanilloid 1 agonist | 0.256 0.005 DBMET03172 0.2 0.012 DBMET03173 0.17 0.023 DBMET03174 | DBMET03172 | |
| 0.223 | 0.007 | 0.235 | Adenylate cyclase stimulant | 0.235 0.005 DBMET03172 0.209 0.01 DBMET03173 0.21 0.01 DBMET03174 0.152 0.059 DBMET03175 0.152 0.06 DBMET03176 | DBMET03172 | |
| 0.215 | 0.005 | 0.215 | Interferon agonist | 0.207 0.005 DBMET03172 0.121 0.017 DBMET03173 0.133 0.013 DBMET03174 | ||
| 0.215 | 0.004 | 0.879 | Acyl-CoA dehydrogenase inhibitor | 0.241 0.003 DBMET03172 0.26 0.003 DBMET03173 0.238 0.003 DBMET03174 0.783 0 DBMET03175 0.879 0 DBMET03176 0.782 0 DBMET03177 | DBMET03176 | |
| 0.326 | 0.117 | 0.479 | Antibacterial | 0.382 0.085 DBMET03172 0.411 0.072 DBMET03173 0.419 0.068 DBMET03174 0.479 0.047 DBMET03175 0.416 0.07 DBMET03176 0.432 0.063 DBMET03177 | DBMET03175 | |
| 0.212 | 0.005 | 0.212 | Toll-Like receptor 4 antagonist | 0.187 0.008 DBMET03172 0.18 0.01 DBMET03173 0.17 0.013 DBMET03174 0.168 0.013 DBMET03175 0.169 0.013 DBMET03176 0.165 0.014 DBMET03177 | ||
| 0.21 | 0.003 | 0.238 | Ca2+-transporting ATPase inhibitor | 0.238 0.002 DBMET03172 0.2 0.004 DBMET03173 0.196 0.004 DBMET03174 | DBMET03172 | |
| 0.238 | 0.031 | 0.45 | Amylase inhibitor | 0.209 0.041 DBMET03172 0.284 0.02 DBMET03173 0.45 0.007 DBMET03174 | DBMET03174 | |
| 0.219 | 0.013 | 0.219 | Carbonic anhydrase III inhibitor | 0.219 0.013 DBMET03172 0.132 0.036 DBMET03173 0.117 0.046 DBMET03174 | ||
| 0.242 | 0.036 | 0.348 | Lipocortins synthesis antagonist | 0.348 0.014 DBMET03172 0.2 0.056 DBMET03173 0.197 0.058 DBMET03174 | DBMET03172 | |
| 0.299 | 0.095 | 0.336 | Transcription factor NF kappa B inhibitor | 0.332 0.082 DBMET03172 0.336 0.081 DBMET03173 0.257 0.122 DBMET03174 | DBMET03173 | |
| 0.205 | 0.005 | 0.205 | Autotaxin inhibitor | 0.051 0.039 DBMET03172 | ||
| 0.205 | 0.006 | 0.933 | Alcohol oxidase inhibitor | 0.496 0.004 DBMET03172 0.933 0.001 DBMET03173 0.845 0.002 DBMET03174 | DBMET03173 | |
| 0.207 | 0.009 | 0.207 | Transcription factor NF kappa B stimulant | 0.117 0.027 DBMET03172 0.077 0.076 DBMET03173 0.097 0.042 DBMET03174 0.144 0.017 DBMET03175 0.144 0.017 DBMET03176 0.14 0.018 DBMET03177 | ||
| 0.293 | 0.099 | 0.38 | Calcium channel activator | 0.38 0.033 DBMET03172 0.314 0.078 DBMET03173 0.368 0.039 DBMET03174 | DBMET03172 | |
| 0.195 | 0.002 | 0.195 | Calcium-dependent phospholipase A2 inhibitor | 0.104 0.003 DBMET03172 | ||
| 0.222 | 0.03 | 0.222 | Interleukin 6 antagonist | 0.195 0.044 DBMET03172 0.156 0.08 DBMET03173 0.129 0.128 DBMET03174 0.156 0.08 DBMET03175 | ||
| 0.21 | 0.018 | 0.677 | Expectorant | 0.178 0.026 DBMET03172 0.285 0.009 DBMET03173 0.294 0.009 DBMET03174 0.677 0.002 DBMET03175 0.572 0.003 DBMET03176 0.577 0.003 DBMET03177 | DBMET03175 | |
| 0.203 | 0.013 | 0.23 | Mucolytic | 0.182 0.018 DBMET03172 0.192 0.015 DBMET03173 0.208 0.012 DBMET03174 0.23 0.008 DBMET03175 0.185 0.017 DBMET03176 0.188 0.016 DBMET03177 | DBMET03175 | |
| 0.198 | 0.007 | 0.634 | Carbamoyl phosphate synthetase inhibitor | 0.256 0.005 DBMET03172 0.423 0.003 DBMET03173 0.46 0.003 DBMET03174 0.634 0.001 DBMET03175 0.617 0.001 DBMET03176 0.558 0.002 DBMET03177 | DBMET03175 | |
| 0.203 | 0.013 | 0.203 | Calcium antagonist | 0.182 0.016 DBMET03172 0.108 0.042 DBMET03173 0.139 0.026 DBMET03174 | ||
| 0.199 | 0.01 | 0.199 | Sphingomyelinase inhibitor | 0.184 0.013 DBMET03172 0.16 0.021 DBMET03173 0.148 0.025 DBMET03174 | ||
| 0.242 | 0.053 | 0.64 | DNA methylase inhibitor | 0.214 0.07 DBMET03172 0.176 0.096 DBMET03174 0.64 0.004 DBMET03175 0.622 0.004 DBMET03176 0.496 0.005 DBMET03177 | DBMET03175 | |
| 0.209 | 0.02 | 0.45 | Ferrochelatase inhibitor | 0.45 0.003 DBMET03172 0.433 0.003 DBMET03173 0.42 0.003 DBMET03174 | DBMET03172 | |
| 0.224 | 0.035 | 0.265 | Antipruritic | 0.265 0.02 DBMET03172 0.143 0.103 DBMET03173 0.134 0.116 DBMET03174 | DBMET03172 | |
| 0.198 | 0.01 | 0.594 | Antimetabolite | 0.114 0.014 DBMET03172 0.074 0.02 DBMET03173 0.079 0.019 DBMET03174 0.584 0.002 DBMET03175 0.594 0.002 DBMET03176 0.454 0.003 DBMET03177 | DBMET03176 | |
| 0.219 | 0.031 | 0.219 | Bone formation stimulant | 0.205 0.034 DBMET03172 0.215 0.032 DBMET03173 0.154 0.056 DBMET03174 | ||
| 0.189 | 0.005 | 0.189 | Ornithine decarboxylase inhibitor | 0.181 0.006 DBMET03172 0.139 0.015 DBMET03173 0.134 0.017 DBMET03174 | ||
| 0.199 | 0.016 | 0.42 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.331 0.005 DBMET03172 0.323 0.005 DBMET03173 0.42 0.004 DBMET03174 | DBMET03174 | |
| 0.246 | 0.063 | 0.416 | Interleukin antagonist | 0.244 0.064 DBMET03172 0.187 0.091 DBMET03173 0.416 0.028 DBMET03174 | DBMET03174 | |
| 0.194 | 0.012 | 0.233 | Selectin antagonist | 0.233 0.009 DBMET03172 0.112 0.024 DBMET03173 0.154 0.017 DBMET03174 | DBMET03172 | |
| 0.183 | 0.003 | 0.183 | Prostaglandin agonist | 0.085 0.006 DBMET03172 0.126 0.004 DBMET03173 0.119 0.005 DBMET03174 | ||
| 0.182 | 0.004 | 0.182 | Potassium channel intermediate-conductance Ca-activated blocker | 0.091 0.012 DBMET03172 | ||
| 0.251 | 0.074 | 0.477 | Superoxide dismutase inhibitor | 0.477 0.015 DBMET03172 0.356 0.035 DBMET03173 0.407 0.025 DBMET03174 | DBMET03172 | |
| 0.227 | 0.052 | 0.309 | Nitric-oxide synthase stimulant | 0.243 0.037 DBMET03172 0.263 0.024 DBMET03173 0.309 0.009 DBMET03174 | DBMET03174 | |
| 0.194 | 0.021 | 0.548 | GABA C receptor agonist | 0.548 0.003 DBMET03172 0.433 0.004 DBMET03173 0.478 0.004 DBMET03174 | DBMET03172 | |
| 0.184 | 0.017 | 0.338 | GABA C receptor antagonist | 0.338 0.004 DBMET03172 0.282 0.005 DBMET03173 0.272 0.005 DBMET03174 | DBMET03172 | |
| 0.191 | 0.024 | 0.241 | Aminopeptidase B inhibitor | 0.231 0.015 DBMET03172 0.235 0.015 DBMET03173 0.241 0.014 DBMET03174 | DBMET03174 | |
| 0.195 | 0.028 | 0.323 | Cholesterol synthesis inhibitor | 0.233 0.02 DBMET03172 0.323 0.009 DBMET03173 0.297 0.012 DBMET03174 | DBMET03173 | |
| 0.171 | 0.004 | 0.171 | Oleamide hydrolase inhibitor | 0.097 0.009 DBMET03172 | ||
| 0.191 | 0.025 | 0.229 | Cathepsin H inhibitor | 0.229 0.016 DBMET03172 0.178 0.03 DBMET03173 0.196 0.023 DBMET03174 | DBMET03172 | |
| 0.196 | 0.031 | 0.255 | Cell wall synthesis inhibitor | 0.255 0.015 DBMET03172 0.253 0.015 DBMET03173 0.24 0.018 DBMET03174 | DBMET03172 | |
| 0.171 | 0.009 | 0.183 | Peroxisome proliferator-activated receptor gamma agonist | 0.183 0.008 DBMET03172 0.172 0.009 DBMET03173 0.172 0.009 DBMET03174 | DBMET03172 | |
| 0.166 | 0.014 | 0.235 | Electrolyte absorption antagonist | 0.235 0.005 DBMET03172 0.209 0.007 DBMET03173 0.2 0.008 DBMET03174 | DBMET03172 | |
| 0.157 | 0.005 | 0.157 | Peroxisome proliferator-activated receptor alpha agonist | 0.093 0.014 DBMET03172 0.116 0.009 DBMET03173 0.093 0.014 DBMET03174 | ||
| 0.16 | 0.009 | 0.16 | Lipase inhibitor | 0.114 0.021 DBMET03172 | ||
| 0.166 | 0.019 | 0.166 | Carbonic anhydrase XIII inhibitor | 0.146 0.022 DBMET03172 0.105 0.036 DBMET03173 0.088 0.044 DBMET03174 | ||
| 0.192 | 0.045 | 0.24 | ATPase inhibitor | 0.211 0.029 DBMET03172 0.24 0.016 DBMET03173 0.228 0.02 DBMET03174 | DBMET03173 | |
| 0.149 | 0.002 | 0.196 | Glucose-6-phosphate isomerase inhibitor | 0.161 0.002 DBMET03172 0.196 0.002 DBMET03173 0.196 0.002 DBMET03174 | DBMET03174 | |
| 0.246 | 0.1 | 0.337 | Insulysin inhibitor | 0.337 0.039 DBMET03172 0.277 0.074 DBMET03173 0.287 0.067 DBMET03174 | DBMET03172 | |
| 0.15 | 0.003 | 0.15 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.057 0.006 DBMET03172 | ||
| 0.155 | 0.009 | 0.155 | Amidase inhibitor | 0.102 0.023 DBMET03172 | ||
| 0.161 | 0.018 | 0.27 | Prolactin inhibitor | 0.27 0.004 DBMET03172 0.168 0.016 DBMET03173 0.156 0.02 DBMET03174 | DBMET03172 | |
| 0.16 | 0.018 | 0.27 | GABA C receptor rho-1 antagonist | 0.27 0.004 DBMET03172 0.237 0.005 DBMET03173 0.234 0.005 DBMET03174 | DBMET03172 | |
| 0.164 | 0.023 | 0.196 | Sphingosine 1-phosphate receptor 4 antagonist | 0.196 0.01 DBMET03172 0.169 0.02 DBMET03173 0.17 0.019 DBMET03174 | DBMET03172 | |
| 0.164 | 0.024 | 0.495 | UDP-glucose 4-epimerase inhibitor | 0.214 0.016 DBMET03172 0.317 0.009 DBMET03173 0.35 0.008 DBMET03174 0.495 0.003 DBMET03175 0.48 0.003 DBMET03176 0.463 0.004 DBMET03177 | DBMET03175 | |
| 0.147 | 0.007 | 0.202 | Glycine receptor agonist | 0.202 0.004 DBMET03172 0.131 0.01 DBMET03173 0.127 0.011 DBMET03174 | DBMET03172 | |
| 0.152 | 0.013 | 0.377 | Glutamate decarboxylase inhibitor | 0.256 0.004 DBMET03172 0.323 0.003 DBMET03173 0.377 0.003 DBMET03174 | DBMET03174 | |
| 0.165 | 0.025 | 0.224 | Sphingosine 1-phosphate receptor 2 antagonist | 0.224 0.005 DBMET03172 0.178 0.016 DBMET03173 0.174 0.018 DBMET03174 | DBMET03172 | |
| 0.194 | 0.055 | 0.309 | Thrombolytic | 0.309 0.022 DBMET03172 0.134 0.095 DBMET03173 0.169 0.068 DBMET03174 | DBMET03172 | |
| 0.154 | 0.016 | 0.188 | Anabolic | 0.188 0.006 DBMET03172 0.169 0.01 DBMET03173 0.168 0.01 DBMET03174 | DBMET03172 | |
| 0.148 | 0.01 | 0.148 | Protein kinase C alpha inhibitor | |||
| 0.153 | 0.016 | 0.237 | Thioredoxin inhibitor | 0.237 0.005 DBMET03172 | DBMET03172 | |
| 0.269 | 0.132 | 0.269 | Toll-Like receptor 7 agonist | |||
| 0.144 | 0.007 | 0.144 | Elastase 1 inhibitor | 0.137 0.008 DBMET03172 | ||
| 0.201 | 0.067 | 0.217 | Nitric oxide antagonist | 0.141 0.104 DBMET03172 0.175 0.079 DBMET03173 0.217 0.062 DBMET03174 | DBMET03174 | |
| 0.143 | 0.011 | 0.146 | Leukotriene antagonist | 0.146 0.011 DBMET03172 0.136 0.012 DBMET03173 0.101 0.021 DBMET03174 | DBMET03172 | |
| 0.134 | 0.005 | 0.147 | Prostaglandin F2 alpha antagonist | 0.142 0.005 DBMET03172 0.147 0.005 DBMET03173 0.111 0.008 DBMET03174 | DBMET03173 | |
| 0.132 | 0.005 | 0.283 | Aconitate hydratase inhibitor | 0.227 0.003 DBMET03172 0.248 0.003 DBMET03173 0.283 0.002 DBMET03174 | DBMET03174 | |
| 0.148 | 0.021 | 0.567 | Alcohol dehydrogenase inhibitor | 0.232 0.009 DBMET03172 0.134 0.027 DBMET03173 0.225 0.01 DBMET03174 0.527 0.003 DBMET03175 0.534 0.003 DBMET03176 0.567 0.003 DBMET03177 | DBMET03177 | |
| 0.137 | 0.011 | 0.188 | Sphingosine 1-phosphate receptor 4 agonist | 0.188 0.005 DBMET03172 0.103 0.024 DBMET03173 0.12 0.016 DBMET03174 | DBMET03172 | |
| 0.22 | 0.095 | 0.253 | Calpain inhibitor | 0.253 0.062 DBMET03172 | DBMET03172 | |
| 0.164 | 0.04 | 0.217 | Sphingosine 1-phosphate receptor 5 antagonist | 0.217 0.006 DBMET03172 0.171 0.032 DBMET03173 0.169 0.035 DBMET03174 | DBMET03172 | |
| 0.144 | 0.022 | 0.165 | Cathepsin G inhibitor | 0.165 0.019 DBMET03172 0.085 0.04 DBMET03173 0.102 0.032 DBMET03174 | DBMET03172 | |
| 0.125 | 0.004 | 0.125 | Nitric oxide donor | 0.097 0.01 DBMET03172 0.099 0.009 DBMET03173 0.088 0.016 DBMET03174 | ||
| 0.127 | 0.006 | 0.146 | Interferon inducer | 0.146 0.005 DBMET03172 0.098 0.013 DBMET03173 0.106 0.01 DBMET03174 | DBMET03172 | |
| 0.134 | 0.013 | 0.322 | Vanilloid agonist | 0.322 0.004 DBMET03172 0.135 0.013 DBMET03173 0.085 0.056 DBMET03174 | DBMET03172 | |
| 0.129 | 0.009 | 0.129 | Beta adrenoreceptor antagonist | 0.07 0.039 DBMET03172 0.077 0.03 DBMET03173 0.099 0.017 DBMET03174 | ||
| 0.212 | 0.092 | 0.228 | Antiamyloidogenic | 0.228 0.082 DBMET03172 | DBMET03172 | |
| 0.17 | 0.051 | 0.284 | GABA C receptor rho-2 antagonist | 0.284 0.007 DBMET03172 0.194 0.032 DBMET03173 0.196 0.031 DBMET03174 | DBMET03172 | |
| 0.176 | 0.059 | 0.245 | Protein-tyrosine phosphatase inhibitor | 0.245 0.032 DBMET03172 0.122 0.111 DBMET03173 0.128 0.104 DBMET03174 | DBMET03172 | |
| 0.138 | 0.023 | 0.143 | Carbonic anhydrase VI inhibitor | 0.143 0.022 DBMET03172 0.084 0.053 DBMET03173 0.075 0.064 DBMET03174 | DBMET03172 | |
| 0.119 | 0.004 | 0.119 | Prostaglandin E2 agonist | 0.047 0.006 DBMET03172 0.081 0.004 DBMET03173 0.075 0.004 DBMET03174 | ||
| 0.228 | 0.116 | 0.307 | Lipoxygenase inhibitor | 0.307 0.068 DBMET03172 | DBMET03172 | |
| 0.116 | 0.005 | 0.128 | Exportin-1 inhibitor | 0.112 0.005 DBMET03172 0.108 0.006 DBMET03173 0.128 0.004 DBMET03174 | DBMET03174 | |
| 0.123 | 0.012 | 0.635 | Ornithine carbamoyltransferase inhibitor | 0.199 0.007 DBMET03172 0.211 0.006 DBMET03173 0.2 0.007 DBMET03174 0.614 0.002 DBMET03175 0.635 0.002 DBMET03176 0.414 0.003 DBMET03177 | DBMET03176 | |
| 0.145 | 0.035 | 0.224 | TRPA1 agonist | 0.224 0.007 DBMET03172 0.165 0.022 DBMET03173 0.143 0.036 DBMET03174 | DBMET03172 | |
| 0.152 | 0.043 | 0.679 | Adenylate cyclase inhibitor | 0.142 0.051 DBMET03172 0.131 0.058 DBMET03173 0.17 0.034 DBMET03174 0.679 0.002 DBMET03175 0.675 0.002 DBMET03176 0.635 0.003 DBMET03177 | DBMET03175 | |
| 0.126 | 0.02 | 0.126 | Interleukin 5 antagonist | 0.106 0.035 DBMET03172 | ||
| 0.137 | 0.03 | 0.247 | Creatine kinase inhibitor | 0.247 0.005 DBMET03172 0.202 0.01 DBMET03173 0.194 0.012 DBMET03174 | DBMET03172 | |
| 0.168 | 0.062 | 0.283 | Diuretic | 0.283 0.025 DBMET03172 0.169 0.062 DBMET03173 0.202 0.043 DBMET03174 | DBMET03172 | |
| 0.13 | 0.024 | 0.638 | NADH dehydrogenase inhibitor | 0.177 0.013 DBMET03172 0.258 0.008 DBMET03173 0.295 0.007 DBMET03174 0.638 0.002 DBMET03175 0.615 0.002 DBMET03176 0.586 0.002 DBMET03177 | DBMET03175 | |
| 0.112 | 0.007 | 0.17 | Glutamate (mGluR6) antagonist | 0.17 0.003 DBMET03172 0.123 0.005 DBMET03173 0.124 0.005 DBMET03174 | DBMET03172 | |
| 0.126 | 0.02 | 0.126 | Hematopoietic | 0.103 0.032 DBMET03172 0.088 0.053 DBMET03174 0.118 0.023 DBMET03175 0.116 0.024 DBMET03176 0.105 0.031 DBMET03177 | ||
| 0.151 | 0.046 | 0.157 | Proteasome inhibitor | 0.157 0.043 DBMET03172 0.105 0.081 DBMET03173 0.146 0.049 DBMET03174 | DBMET03172 | |
| 0.105 | 0.001 | 0.105 | Carbonic anhydrase VIII inhibitor | 0.085 0.001 DBMET03172 0.054 0.002 DBMET03173 0.049 0.003 DBMET03174 | ||
| 0.105 | 0.001 | 0.105 | Carbonic anhydrase X inhibitor | 0.085 0.001 DBMET03172 0.054 0.002 DBMET03173 0.049 0.003 DBMET03174 | ||
| 0.115 | 0.012 | 0.135 | Estrogen-related receptor beta agonist | 0.135 0.005 DBMET03172 0.113 0.014 DBMET03173 0.114 0.013 DBMET03174 | DBMET03172 | |
| 0.123 | 0.021 | 0.146 | Glutathione S-transferase inhibitor | 0.146 0.013 DBMET03172 0.094 0.043 DBMET03173 0.11 0.029 DBMET03174 | DBMET03172 | |
| 0.113 | 0.011 | 0.299 | Neuraminidase inhibitor | 0.071 0.033 DBMET03172 0.299 0.003 DBMET03173 0.135 0.008 DBMET03174 | DBMET03173 | |
| 0.133 | 0.032 | 0.228 | Electron transport complex I inhibitor | 0.215 0.007 DBMET03172 0.228 0.006 DBMET03173 0.118 0.05 DBMET03174 | DBMET03173 | |
| 0.117 | 0.016 | 0.321 | Argininosuccinate synthase inhibitor | 0.25 0.005 DBMET03172 0.222 0.006 DBMET03173 0.214 0.007 DBMET03174 0.312 0.004 DBMET03175 0.321 0.004 DBMET03176 0.218 0.007 DBMET03177 | DBMET03176 | |
| 0.118 | 0.017 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 DBMET03172 0.113 0.021 DBMET03173 0.107 0.025 DBMET03174 | ||
| 0.147 | 0.047 | 0.205 | Protein-tyrosine phosphatase 1B inhibitor | 0.205 0.028 DBMET03172 0.104 0.074 DBMET03173 0.109 0.07 DBMET03174 | DBMET03172 | |
| 0.119 | 0.019 | 0.182 | Glycine receptor antagonist | 0.182 0.004 DBMET03172 0.12 0.018 DBMET03173 0.113 0.022 DBMET03174 | DBMET03172 | |
| 0.101 | 0.003 | 0.101 | Prostaglandin EP2 agonist | 0.057 0.005 DBMET03172 0.056 0.005 DBMET03173 0.068 0.004 DBMET03174 | ||
| 0.275 | 0.176 | 0.275 | DNA directed DNA polymerase inhibitor | |||
| 0.156 | 0.058 | 0.156 | Cytokine production inhibitor | |||
| 0.153 | 0.056 | 0.171 | Neurotrophic factor | 0.171 0.043 DBMET03172 | DBMET03172 | |
| 0.136 | 0.039 | 0.156 | Caspase 3 inhibitor | 0.156 0.024 DBMET03172 0.116 0.066 DBMET03173 0.133 0.043 DBMET03174 | DBMET03172 | |
| 0.109 | 0.012 | 0.109 | Protease 3C (Human rhinovirus) inhibitor | 0.102 0.015 DBMET03172 0.069 0.038 DBMET03173 0.081 0.027 DBMET03174 | ||
| 0.112 | 0.016 | 0.246 | Prostaglandin EP2 antagonist | 0.2 0.006 DBMET03172 0.246 0.005 DBMET03173 0.137 0.011 DBMET03174 | DBMET03173 | |
| 0.156 | 0.061 | 0.166 | Hemostatic | 0.166 0.051 DBMET03172 0.119 0.117 DBMET03173 0.119 0.116 DBMET03174 | DBMET03172 | |
| 0.158 | 0.063 | 0.294 | Lipid peroxidase inhibitor | 0.246 0.028 DBMET03172 0.177 0.052 DBMET03173 0.294 0.02 DBMET03174 | DBMET03174 | |
| 0.098 | 0.005 | 0.098 | Cholesterol esterase inhibitor | 0.074 0.009 DBMET03172 0.044 0.039 DBMET03173 | ||
| 0.109 | 0.017 | 0.28 | Ribonucleoside-diphosphate reductase inhibitor | 0.098 0.02 DBMET03172 0.112 0.017 DBMET03173 0.108 0.018 DBMET03174 0.261 0.004 DBMET03175 0.28 0.004 DBMET03176 0.181 0.008 DBMET03177 | DBMET03176 | |
| 0.096 | 0.005 | 0.096 | Retinoid X receptor agonist | 0.075 0.009 DBMET03172 0.057 0.015 DBMET03173 0.066 0.012 DBMET03174 | ||
| 0.109 | 0.019 | 0.362 | Ribonucleotide reductase inhibitor | 0.098 0.021 DBMET03172 0.111 0.018 DBMET03173 0.108 0.019 DBMET03174 0.35 0.004 DBMET03175 0.362 0.003 DBMET03176 0.228 0.006 DBMET03177 | DBMET03176 | |
| 0.105 | 0.015 | 0.271 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET03172 0.271 0.003 DBMET03173 0.123 0.011 DBMET03174 | DBMET03173 | |
| 0.115 | 0.025 | 0.126 | Bile acid receptor antagonist | 0.126 0.015 DBMET03172 0.11 0.032 DBMET03173 0.116 0.023 DBMET03174 | DBMET03172 | |
| 0.1 | 0.011 | 0.125 | Thromboxane antagonist | 0.113 0.008 DBMET03172 0.125 0.006 DBMET03173 0.097 0.012 DBMET03174 | DBMET03173 | |
| 0.102 | 0.015 | 0.137 | Vanilloid 4 agonist | 0.137 0.004 DBMET03172 0.11 0.011 DBMET03173 0.108 0.012 DBMET03174 | DBMET03172 | |
| 0.089 | 0.003 | 0.089 | Lysophosphatidic acid 1 receptor antagonist | 0.038 0.005 DBMET03172 0.031 0.006 DBMET03173 0.026 0.009 DBMET03174 | ||
| 0.13 | 0.044 | 0.13 | Transcription factor STAT6 inhibitor | 0.119 0.062 DBMET03172 | ||
| 0.086 | 0.002 | 0.086 | Prostaglandin F2 alpha agonist | 0.066 0.003 DBMET03172 0.07 0.003 DBMET03173 0.066 0.003 DBMET03174 | ||
| 0.094 | 0.012 | 0.094 | Beta 1 adrenoreceptor antagonist | 0.064 0.032 DBMET03172 0.072 0.024 DBMET03173 0.087 0.014 DBMET03174 | ||
| 0.092 | 0.01 | 0.112 | Thromboxane A2 antagonist | 0.102 0.007 DBMET03172 0.112 0.005 DBMET03173 0.089 0.011 DBMET03174 | DBMET03173 | |
| 0.107 | 0.025 | 0.219 | Aminopeptidase I inhibitor | 0.148 0.013 DBMET03172 0.203 0.007 DBMET03173 0.219 0.006 DBMET03174 | DBMET03174 | |
| 0.089 | 0.007 | 0.089 | Squalene synthetase inhibitor | 0.067 0.01 DBMET03172 0.054 0.013 DBMET03173 0.052 0.014 DBMET03174 | ||
| 0.09 | 0.008 | 0.105 | Thromboxane synthase inhibitor | 0.105 0.005 DBMET03172 0.063 0.024 DBMET03173 0.068 0.019 DBMET03174 | DBMET03172 | |
| 0.091 | 0.011 | 0.091 | Glucosylceramidase inhibitor | 0.08 0.015 DBMET03172 0.053 0.042 DBMET03173 0.055 0.037 DBMET03174 | ||
| 0.098 | 0.019 | 0.502 | Biliverdin reductase inhibitor | 0.176 0.007 DBMET03172 0.255 0.004 DBMET03173 0.281 0.004 DBMET03174 0.502 0.001 DBMET03175 0.48 0.001 DBMET03176 0.411 0.002 DBMET03177 | DBMET03175 | |
| 0.116 | 0.038 | 0.139 | Interleukin 1 beta converting enzyme inhibitor | 0.139 0.022 DBMET03172 0.089 0.074 DBMET03173 0.089 0.073 DBMET03174 | DBMET03172 | |
| 0.09 | 0.012 | 0.113 | Leukotriene B4 antagonist | 0.111 0.008 DBMET03172 0.113 0.008 DBMET03173 0.075 0.017 DBMET03174 | DBMET03173 | |
| 0.087 | 0.009 | 0.134 | Alpha-mannosidase inhibitor | 0.103 0.006 DBMET03172 0.113 0.005 DBMET03173 0.134 0.004 DBMET03174 | DBMET03174 | |
| 0.105 | 0.028 | 0.141 | Keratolytic | 0.132 0.018 DBMET03172 0.132 0.018 DBMET03173 0.141 0.016 DBMET03174 | DBMET03174 | |
| 0.081 | 0.004 | 0.081 | Calcium-sensing receptor antagonist | 0.014 0.012 DBMET03174 | ||
| 0.082 | 0.007 | 0.087 | Leukotriene C antagonist | 0.087 0.005 DBMET03172 0.073 0.011 DBMET03173 0.066 0.019 DBMET03174 | DBMET03172 | |
| 0.104 | 0.03 | 0.147 | Granulocyte macrophage colony stimulating factor agonist | 0.147 0.005 DBMET03172 0.118 0.017 DBMET03173 0.117 0.018 DBMET03174 | DBMET03172 | |
| 0.14 | 0.066 | 0.165 | Farnesoid X receptor antagonist | 0.165 0.038 DBMET03172 | DBMET03172 | |
| 0.082 | 0.009 | 0.118 | Adenosine deaminase inhibitor | 0.082 0.009 DBMET03172 0.08 0.009 DBMET03173 0.097 0.006 DBMET03174 0.114 0.004 DBMET03175 0.118 0.004 DBMET03176 0.092 0.007 DBMET03177 | DBMET03176 | |
| 0.091 | 0.018 | 0.104 | Carbonic anhydrase VB inhibitor | 0.104 0.015 DBMET03172 0.057 0.038 DBMET03173 0.051 0.044 DBMET03174 | DBMET03172 | |
| 0.082 | 0.011 | 0.082 | Beta 2 adrenoreceptor antagonist | 0.054 0.031 DBMET03172 0.06 0.024 DBMET03173 0.061 0.023 DBMET03174 | ||
| 0.08 | 0.009 | 0.135 | Mannosidase inhibitor | 0.099 0.006 DBMET03172 0.135 0.004 DBMET03173 0.12 0.005 DBMET03174 | DBMET03173 | |
| 0.098 | 0.026 | 0.101 | Epoxide hydrolase inhibitor | 0.101 0.024 DBMET03172 | DBMET03172 | |
| 0.075 | 0.004 | 0.111 | Prostaglandin EP4 agonist | 0.052 0.005 DBMET03172 0.111 0.003 DBMET03173 0.062 0.004 DBMET03174 | DBMET03173 | |
| 0.139 | 0.068 | 0.167 | Nav1.6 sodium channel blocker | 0.167 0.038 DBMET03172 0.116 0.103 DBMET03174 | DBMET03172 | |
| 0.093 | 0.023 | 0.159 | GABA B receptor agonist | 0.159 0.004 DBMET03172 0.14 0.005 DBMET03173 0.145 0.004 DBMET03174 | DBMET03172 | |
| 0.089 | 0.021 | 0.767 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 DBMET03172 0.063 0.036 DBMET03173 0.084 0.023 DBMET03174 0.767 0.001 DBMET03175 0.67 0.002 DBMET03176 0.576 0.002 DBMET03177 | DBMET03175 | |
| 0.146 | 0.078 | 0.15 | Cytidine deaminase inhibitor | 0.128 0.093 DBMET03172 0.15 0.075 DBMET03173 | DBMET03173 | |
| 0.075 | 0.008 | 0.35 | Fumarate hydratase inhibitor | 0.147 0.004 DBMET03172 0.285 0.003 DBMET03173 0.35 0.002 DBMET03174 0.29 0.003 DBMET03175 0.227 0.003 DBMET03176 0.12 0.004 DBMET03177 | DBMET03174 | |
| 0.081 | 0.013 | 0.081 | Lipocortins synthesis agonist | 0.078 0.015 DBMET03172 0.057 0.042 DBMET03173 0.054 0.051 DBMET03174 | ||
| 0.071 | 0.004 | 0.158 | Prostacyclin agonist | 0.158 0.003 DBMET03172 0.116 0.003 DBMET03173 0.065 0.004 DBMET03174 | DBMET03172 | |
| 0.12 | 0.053 | 0.12 | Protein kinase C gamma inhibitor | 0.107 0.067 DBMET03172 | ||
| 0.066 | 0.003 | 0.066 | Toll-Like receptor 8 agonist | 0.029 0.005 DBMET03172 | ||
| 0.082 | 0.019 | 0.427 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.096 0.015 DBMET03172 0.154 0.008 DBMET03173 0.174 0.008 DBMET03174 0.427 0.002 DBMET03175 0.407 0.002 DBMET03176 0.38 0.002 DBMET03177 | DBMET03175 | |
| 0.087 | 0.025 | 0.133 | Phospholipase D inhibitor | 0.133 0.004 DBMET03172 0.087 0.025 DBMET03173 0.086 0.026 DBMET03174 | DBMET03172 | |
| 0.069 | 0.007 | 0.069 | Microtubule stabilization | 0.041 0.04 DBMET03172 0.05 0.027 DBMET03173 0.055 0.022 DBMET03174 | ||
| 0.078 | 0.017 | 0.111 | Sphingosine kinase inhibitor | 0.095 0.009 DBMET03172 0.111 0.005 DBMET03173 0.083 0.014 DBMET03174 | DBMET03173 | |
| 0.098 | 0.037 | 0.399 | Porphobilinogen synthase inhibitor | 0.399 0.004 DBMET03172 0.251 0.008 DBMET03173 0.292 0.005 DBMET03174 | DBMET03172 | |
| 0.154 | 0.093 | 0.225 | Neurotensin receptor agonist | 0.225 0.026 DBMET03172 0.166 0.069 DBMET03173 0.165 0.071 DBMET03174 | DBMET03172 | |
| 0.077 | 0.018 | 0.077 | Carbonic anhydrase XIV inhibitor | 0.072 0.019 DBMET03172 0.044 0.04 DBMET03173 0.043 0.042 DBMET03174 | ||
| 0.072 | 0.013 | 0.083 | Adenine nucleotide translocase inhibitor | 0.061 0.026 DBMET03172 0.082 0.008 DBMET03173 0.083 0.008 DBMET03174 0.062 0.025 DBMET03175 0.062 0.024 DBMET03176 0.06 0.028 DBMET03177 | DBMET03174 | |
| 0.063 | 0.005 | 0.077 | Prostaglandin D2 agonist | 0.077 0.004 DBMET03172 0.06 0.005 DBMET03173 0.072 0.004 DBMET03174 | DBMET03172 | |
| 0.085 | 0.027 | 0.104 | Peroxisome proliferator-activated receptor gamma antagonist | 0.098 0.016 DBMET03172 0.1 0.015 DBMET03173 0.104 0.014 DBMET03174 | DBMET03174 | |
| 0.112 | 0.054 | 0.152 | Protease inhibitor | 0.152 0.029 DBMET03173 0.15 0.029 DBMET03174 | DBMET03173 | |
| 0.07 | 0.015 | 0.948 | Purinergic P2Y antagonist | 0.106 0.009 DBMET03172 0.059 0.02 DBMET03173 0.076 0.014 DBMET03174 0.941 0 DBMET03175 0.948 0 DBMET03176 0.835 0.001 DBMET03177 | DBMET03176 | |
| 0.09 | 0.036 | 0.285 | Histidine decarboxylase inhibitor | 0.16 0.018 DBMET03172 0.24 0.009 DBMET03173 0.285 0.007 DBMET03174 | DBMET03174 | |
| 0.083 | 0.028 | 0.087 | Potassium channel (Tandem pore domain) blocker | 0.087 0.021 DBMET03172 0.071 0.062 DBMET03173 0.072 0.056 DBMET03174 | DBMET03172 | |
| 0.063 | 0.009 | 0.101 | Membrane dipeptidase inhibitor | 0.101 0.004 DBMET03172 0.076 0.006 DBMET03173 0.075 0.006 DBMET03174 | DBMET03172 | |
| 0.057 | 0.003 | 0.062 | Calcium-independent phospholipase A2 inhibitor | 0.062 0.003 DBMET03172 0.036 0.019 DBMET03173 0.033 0.029 DBMET03174 | DBMET03172 | |
| 0.069 | 0.016 | 0.092 | Pregnane X receptor antagonist | 0.092 0.004 DBMET03172 0.068 0.017 DBMET03173 0.068 0.017 DBMET03174 | DBMET03172 | |
| 0.064 | 0.011 | 0.095 | Geranyltranstransferase inhibitor | 0.095 0.004 DBMET03172 0.076 0.005 DBMET03173 0.08 0.005 DBMET03174 | DBMET03172 | |
| 0.057 | 0.004 | 0.061 | Elastase 3B inhibitor | 0.061 0.003 DBMET03172 | DBMET03172 | |
| 0.057 | 0.004 | 0.061 | Elastase 3A inhibitor | 0.061 0.003 DBMET03172 | DBMET03172 | |
| 0.057 | 0.004 | 0.061 | Elastase 2B inhibitor | 0.061 0.003 DBMET03172 | DBMET03172 | |
| 0.073 | 0.022 | 0.104 | Sphingosine 1-phosphate receptor 3 antagonist | 0.104 0.007 DBMET03172 0.073 0.022 DBMET03173 0.082 0.016 DBMET03174 | DBMET03172 | |
| 0.074 | 0.023 | 0.074 | Potassium channel (Ca-activated) blocker | |||
| 0.057 | 0.007 | 0.062 | Leukotriene C4 antagonist | 0.062 0.005 DBMET03172 0.049 0.011 DBMET03173 0.043 0.018 DBMET03174 | DBMET03172 | |
| 0.113 | 0.063 | 0.157 | GABA receptor agonist | 0.157 0.032 DBMET03172 | DBMET03172 | |
| 0.087 | 0.038 | 0.15 | GABA aminotransferase inhibitor | 0.15 0.008 DBMET03172 0.119 0.016 DBMET03173 0.125 0.014 DBMET03174 | DBMET03172 | |
| 0.061 | 0.012 | 0.076 | Cytokine production stimulant | 0.076 0.005 DBMET03172 0.067 0.008 DBMET03173 0.073 0.006 DBMET03174 | DBMET03172 | |
| 0.082 | 0.036 | 0.23 | Leukotriene synthesis inhibitor | 0.23 0.005 DBMET03172 0.133 0.013 DBMET03173 0.081 0.037 DBMET03174 | DBMET03172 | |
| 0.074 | 0.028 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 DBMET03172 0.075 0.028 DBMET03173 0.077 0.025 DBMET03174 | DBMET03174 | |
| 0.103 | 0.058 | 0.121 | Xanthine oxidase inhibitor | 0.113 0.051 DBMET03172 0.092 0.069 DBMET03173 0.121 0.047 DBMET03174 | DBMET03174 | |
| 0.058 | 0.014 | 0.084 | Sphingosine 1-phosphate receptor 1 agonist | 0.075 0.007 DBMET03172 0.082 0.005 DBMET03173 0.084 0.005 DBMET03174 | DBMET03174 | |
| 0.068 | 0.023 | 0.083 | Sphingosine kinase 2 inhibitor | 0.083 0.014 DBMET03172 0.069 0.022 DBMET03173 0.069 0.023 DBMET03174 | DBMET03172 | |
| 0.069 | 0.025 | 0.178 | Acetyl-CoA transferase inhibitor | 0.178 0.005 DBMET03172 | DBMET03172 | |
| 0.058 | 0.015 | 0.071 | Benzodiazepine antagonist | 0.071 0.007 DBMET03172 | DBMET03172 | |
| 0.066 | 0.022 | 0.098 | Acetyl-CoA transferase 2 inhibitor | 0.098 0.005 DBMET03172 | DBMET03172 | |
| 0.052 | 0.009 | 0.162 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.042 0.011 DBMET03172 0.046 0.01 DBMET03173 0.045 0.01 DBMET03174 0.162 0.001 DBMET03175 0.157 0.001 DBMET03176 0.138 0.001 DBMET03177 | DBMET03175 | |
| 0.06 | 0.017 | 0.099 | Sphingosine 1-phosphate receptor agonist | 0.082 0.008 DBMET03172 0.097 0.006 DBMET03173 0.099 0.005 DBMET03174 | DBMET03174 | |
| 0.08 | 0.037 | 0.359 | Phenylalanine 4-hydroxylase inhibitor | 0.127 0.016 DBMET03172 0.248 0.005 DBMET03173 0.359 0.003 DBMET03174 | DBMET03174 | |
| 0.047 | 0.004 | 0.048 | Toll-Like receptor 4 agonist | 0.037 0.006 DBMET03172 0.046 0.004 DBMET03173 0.038 0.005 DBMET03174 0.048 0.004 DBMET03175 0.048 0.004 DBMET03176 0.046 0.004 DBMET03177 | DBMET03176 | |
| 0.118 | 0.076 | 0.13 | Nav1.3 sodium channel blocker | 0.13 0.064 DBMET03172 0.111 0.085 DBMET03174 | DBMET03172 | |
| 0.204 | 0.163 | 0.204 | Caspase 3 stimulant | |||
| 0.059 | 0.018 | 0.08 | Adenylate cyclase 1 inhibitor | 0.073 0.011 DBMET03172 0.056 0.021 DBMET03173 0.08 0.008 DBMET03174 | DBMET03174 | |
| 0.078 | 0.038 | 0.098 | Carbonic anhydrase VA inhibitor | 0.098 0.026 DBMET03172 | DBMET03172 | |
| 0.049 | 0.008 | 0.058 | Uridine phosphorylase inhibitor | 0.048 0.009 DBMET03172 0.058 0.006 DBMET03173 0.056 0.006 DBMET03174 | DBMET03173 | |
| 0.053 | 0.013 | 0.079 | GABA uptake inhibitor | 0.079 0.005 DBMET03172 0.072 0.006 DBMET03173 0.079 0.005 DBMET03174 | DBMET03174 | |
| 0.064 | 0.024 | 0.101 | Sphingosine 1-phosphate receptor 1 antagonist | 0.101 0.009 DBMET03172 0.068 0.02 DBMET03173 0.066 0.022 DBMET03174 | DBMET03172 | |
| 0.051 | 0.012 | 0.051 | Peroxisome proliferator-activated receptor delta agonist | 0.042 0.016 DBMET03172 0.05 0.013 DBMET03173 0.038 0.018 DBMET03174 | ||
| 0.186 | 0.147 | 0.248 | Neuropeptide Y2 antagonist | 0.248 0.058 DBMET03172 0.222 0.086 DBMET03173 0.219 0.09 DBMET03174 | DBMET03172 | |
| 0.041 | 0.003 | 0.041 | Isoleucine-tRNA ligase inhibitor | 0.039 0.003 DBMET03172 0.034 0.004 DBMET03173 0.035 0.004 DBMET03174 | ||
| 0.072 | 0.034 | 0.078 | Cannabinoid CB1 receptor agonist | 0.078 0.029 DBMET03172 | DBMET03172 | |
| 0.049 | 0.012 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.02 DBMET03172 | ||
| 0.131 | 0.095 | 0.188 | Thiol protease inhibitor | 0.188 0.044 DBMET03172 0.153 0.066 DBMET03173 0.136 0.085 DBMET03174 | DBMET03172 | |
| 0.05 | 0.014 | 0.093 | Kainate receptor agonist | 0.093 0.003 DBMET03172 0.077 0.004 DBMET03173 0.076 0.004 DBMET03174 | DBMET03172 | |
| 0.079 | 0.044 | 0.163 | CDC25A inhibitor | 0.163 0.011 DBMET03172 | DBMET03172 | |
| 0.045 | 0.01 | 0.778 | HMG CoA reductase inhibitor | 0.103 0.002 DBMET03172 0.778 0.001 DBMET03173 0.438 0.001 DBMET03174 | DBMET03173 | |
| 0.043 | 0.008 | 0.122 | Purinergic P2Y12 antagonist | 0.122 0.004 DBMET03172 0.024 0.015 DBMET03173 0.033 0.011 DBMET03174 0.07 0.005 DBMET03175 0.071 0.005 DBMET03176 0.061 0.005 DBMET03177 | DBMET03172 | |
| 0.06 | 0.025 | 0.165 | Glycine transporter 2 inhibitor | 0.165 0.007 DBMET03172 0.058 0.026 DBMET03173 0.066 0.022 DBMET03174 | DBMET03172 | |
| 0.08 | 0.046 | 0.114 | Sphingosine 1-phosphate receptor antagonist | 0.114 0.015 DBMET03172 0.08 0.046 DBMET03173 0.08 0.046 DBMET03174 | DBMET03172 | |
| 0.036 | 0.002 | 0.036 | Carbonic anhydrase XI inhibitor | 0.034 0.003 DBMET03172 0.017 0.005 DBMET03173 0.016 0.005 DBMET03174 | ||
| 0.105 | 0.072 | 0.215 | Cystathionine beta-synthase inhibitor | 0.215 0.021 DBMET03172 0.168 0.034 DBMET03173 0.191 0.027 DBMET03174 | DBMET03172 | |
| 0.056 | 0.024 | 0.08 | Squalene epoxidase inhibitor | 0.08 0.01 DBMET03172 0.071 0.013 DBMET03173 0.058 0.023 DBMET03174 | DBMET03172 | |
| 0.059 | 0.027 | 0.129 | Sphingosine 1-phosphate receptor 5 agonist | 0.129 0.005 DBMET03172 0.068 0.018 DBMET03173 0.079 0.013 DBMET03174 | DBMET03172 | |
| 0.036 | 0.005 | 0.059 | Vanilloid 2 agonist | 0.059 0.002 DBMET03172 0.039 0.004 DBMET03173 0.037 0.005 DBMET03174 | DBMET03172 | |
| 0.072 | 0.041 | 0.098 | Acetylcholine M5 receptor agonist | 0.098 0.021 DBMET03172 | DBMET03172 | |
| 0.115 | 0.084 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.064 DBMET03172 | DBMET03172 | |
| 0.058 | 0.027 | 0.058 | Diacylglycerol O-acyltransferase inhibitor | 0.049 0.038 DBMET03172 | ||
| 0.049 | 0.019 | 0.124 | Thymidine kinase inhibitor | 0.049 0.019 DBMET03172 0.043 0.026 DBMET03173 0.049 0.02 DBMET03174 0.124 0.005 DBMET03175 0.119 0.005 DBMET03176 0.096 0.007 DBMET03177 | DBMET03175 | |
| 0.036 | 0.007 | 0.047 | Elastase 2 inhibitor | 0.047 0.005 DBMET03172 | DBMET03172 | |
| 0.036 | 0.007 | 0.047 | Elastase 2A inhibitor | 0.047 0.005 DBMET03172 | DBMET03172 | |
| 0.045 | 0.016 | 0.4 | Phosphoglycerate kinase inhibitor | 0.055 0.012 DBMET03172 0.051 0.014 DBMET03173 0.087 0.008 DBMET03174 0.4 0.002 DBMET03175 0.393 0.002 DBMET03176 0.26 0.003 DBMET03177 | DBMET03175 | |
| 0.133 | 0.104 | 0.231 | Heat shock protein 70 antagonist | 0.167 0.02 DBMET03172 0.137 0.086 DBMET03173 0.146 0.055 DBMET03174 0.231 0.004 DBMET03175 0.219 0.005 DBMET03176 0.181 0.011 DBMET03177 | DBMET03175 | |
| 0.071 | 0.042 | 0.096 | Carbonic anhydrase V inhibitor | 0.096 0.028 DBMET03172 | DBMET03172 | |
| 0.14 | 0.113 | 0.155 | Tumour necrosis factor antagonist | 0.155 0.095 DBMET03172 | DBMET03172 | |
| 0.096 | 0.069 | 0.096 | Bronchodilator | 0.089 0.076 DBMET03174 | ||
| 0.03 | 0.003 | 0.038 | Thromboxane A2 agonist | 0.038 0.003 DBMET03172 0.03 0.003 DBMET03173 0.03 0.003 DBMET03174 | DBMET03172 | |
| 0.045 | 0.018 | 0.078 | Arginase inhibitor | 0.078 0.006 DBMET03172 0.058 0.011 DBMET03173 0.063 0.009 DBMET03174 | DBMET03172 | |
| 0.056 | 0.029 | 0.073 | Vanilloid 2 antagonist | 0.073 0.012 DBMET03172 0.069 0.014 DBMET03173 | DBMET03172 | |
| 0.054 | 0.028 | 0.126 | Plasminogen activator inhibitor antagonist | 0.126 0.006 DBMET03172 | DBMET03172 | |
| 0.063 | 0.037 | 0.079 | Androgen agonist | 0.079 0.024 DBMET03172 0.057 0.046 DBMET03174 | DBMET03172 | |
| 0.078 | 0.053 | 0.079 | Macrophage migration inhibitory factor inhibitor | 0.079 0.052 DBMET03172 | DBMET03172 | |
| 0.047 | 0.023 | 0.064 | GABA B receptor antagonist | 0.064 0.01 DBMET03172 0.055 0.015 DBMET03173 0.05 0.02 DBMET03174 | DBMET03172 | |
| 0.058 | 0.033 | 0.058 | Angiotensin-converting enzyme inhibitor | 0.054 0.039 DBMET03172 0.055 0.037 DBMET03174 0.053 0.04 DBMET03175 | ||
| 0.039 | 0.014 | 0.087 | ATP citrate lysase inhibitor | 0.07 0.004 DBMET03172 0.087 0.004 DBMET03173 0.06 0.005 DBMET03174 | DBMET03173 | |
| 0.098 | 0.074 | 0.118 | AMP-activated protein kinase stimulant | 0.11 0.059 DBMET03172 0.118 0.05 DBMET03173 0.117 0.052 DBMET03174 | DBMET03173 | |
| 0.106 | 0.082 | 0.175 | Beta amyloid protein antagonist | 0.175 0.026 DBMET03172 0.096 0.095 DBMET03173 0.116 0.071 DBMET03174 | DBMET03172 | |
| 0.069 | 0.045 | 0.12 | Glutamate (mGluR7) antagonist | 0.12 0.005 DBMET03172 0.091 0.017 DBMET03173 0.089 0.018 DBMET03174 | DBMET03172 | |
| 0.051 | 0.027 | 0.051 | Carbonic anhydrase VII inhibitor | |||
| 0.036 | 0.014 | 0.1 | Leukotriene B4 receptor 1 antagonist | 0.1 0.004 DBMET03172 0.051 0.007 DBMET03173 0.033 0.016 DBMET03174 | DBMET03172 | |
| 0.032 | 0.01 | 0.043 | Hedgehog signaling activator | 0.043 0.004 DBMET03172 0.04 0.005 DBMET03173 0.034 0.008 DBMET03174 | DBMET03172 | |
| 0.093 | 0.072 | 0.111 | Nitric-oxide synthase inhibitor | 0.111 0.045 DBMET03172 | DBMET03172 | |
| 0.025 | 0.003 | 0.034 | Thromboxane agonist | 0.034 0.003 DBMET03172 0.024 0.003 DBMET03173 0.022 0.004 DBMET03174 | DBMET03172 | |
| 0.083 | 0.062 | 0.108 | Androgen antagonist | 0.083 0.062 DBMET03172 0.078 0.069 DBMET03173 0.108 0.041 DBMET03174 | DBMET03174 | |
| 0.041 | 0.02 | 0.078 | Glutamate (mGluR8) agonist | 0.078 0.004 DBMET03172 0.064 0.006 DBMET03173 0.071 0.005 DBMET03174 | DBMET03172 | |
| 0.063 | 0.042 | 0.063 | Caspase 9 inhibitor | 0.06 0.048 DBMET03172 0.058 0.051 DBMET03174 | ||
| 0.044 | 0.024 | 0.074 | Acetyl-CoA transferase 1 inhibitor | 0.074 0.006 DBMET03172 | DBMET03172 | |
| 0.272 | 0.252 | 0.449 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.449 0.062 DBMET03172 0.364 0.136 DBMET03173 0.391 0.109 DBMET03174 | DBMET03172 | |
| 0.045 | 0.025 | 0.06 | Angiotensin AT1 receptor antagonist | 0.06 0.006 DBMET03172 0.042 0.029 DBMET03173 0.046 0.023 DBMET03174 | DBMET03172 | |
| 0.024 | 0.005 | 0.037 | Vitamin D receptor agonist | 0.025 0.004 DBMET03172 0.037 0.003 DBMET03173 0.025 0.004 DBMET03174 | DBMET03173 | |
| 0.04 | 0.021 | 0.057 | Vanilloid 3 antagonist | 0.057 0.005 DBMET03172 0.039 0.024 DBMET03173 0.04 0.023 DBMET03174 | DBMET03172 | |
| 0.025 | 0.007 | 0.044 | Neuraminidase (Influenza B) inhibitor | 0.034 0.004 DBMET03172 0.044 0.003 DBMET03173 0.039 0.003 DBMET03174 | DBMET03173 | |
| 0.123 | 0.105 | 0.158 | Acetylcholine M1 receptor antagonist | 0.158 0.068 DBMET03172 0.122 0.106 DBMET03173 0.117 0.112 DBMET03174 | DBMET03172 | |
| 0.035 | 0.017 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.044 0.009 DBMET03172 0.037 0.015 DBMET03173 0.039 0.012 DBMET03174 | DBMET03172 | |
| 0.032 | 0.014 | 0.046 | Purinergic P2Y15 antagonist | 0.046 0.005 DBMET03172 0.036 0.01 DBMET03173 0.035 0.01 DBMET03174 | DBMET03172 | |
| 0.07 | 0.053 | 0.074 | Calcium channel L-type blocker | 0.074 0.047 DBMET03172 | DBMET03172 | |
| 0.076 | 0.059 | 0.124 | Acetylcholine nicotinic antagonist | 0.124 0.029 DBMET03172 | DBMET03172 | |
| 0.131 | 0.115 | 0.195 | CF transmembrane conductance regulator agonist | 0.195 0.025 DBMET03172 0.15 0.077 DBMET03173 0.165 0.053 DBMET03174 | DBMET03172 | |
| 0.044 | 0.028 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET03172 | DBMET03172 | |
| 0.037 | 0.021 | 0.054 | Calcitonin receptor agonist | 0.049 0.017 DBMET03172 0.042 0.019 DBMET03173 0.054 0.016 DBMET03174 | DBMET03174 | |
| 0.022 | 0.006 | 0.548 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 DBMET03172 0.026 0.003 DBMET03173 0.028 0.003 DBMET03174 0.548 0 DBMET03175 0.503 0 DBMET03176 0.404 0 DBMET03177 | DBMET03175 | |
| 0.166 | 0.15 | 0.211 | 5 Hydroxytryptamine 3E antagonist | 0.211 0.047 DBMET03172 0.163 0.159 DBMET03174 | DBMET03172 | |
| 0.084 | 0.069 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.085 0.067 DBMET03172 0.121 0.019 DBMET03173 0.128 0.015 DBMET03174 | DBMET03174 | |
| 0.034 | 0.019 | 0.053 | Glutamate (mGluR3) agonist | 0.053 0.004 DBMET03172 0.041 0.009 DBMET03173 0.043 0.008 DBMET03174 | DBMET03172 | |
| 0.021 | 0.006 | 0.139 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET03172 0.015 0.011 DBMET03173 0.015 0.012 DBMET03174 0.137 0.001 DBMET03175 0.139 0.001 DBMET03176 0.098 0.001 DBMET03177 | DBMET03176 | |
| 0.029 | 0.015 | 0.04 | Glucosylceramidase stimulant | 0.04 0.004 DBMET03172 | DBMET03172 | |
| 0.122 | 0.109 | 0.134 | Anticoagulant | 0.134 0.096 DBMET03172 | DBMET03172 | |
| 0.045 | 0.032 | 0.148 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 DBMET03172 0.148 0.003 DBMET03173 0.063 0.01 DBMET03174 | DBMET03173 | |
| 0.058 | 0.045 | 0.09 | Ryanodine receptor antagonist | 0.09 0.005 DBMET03172 0.063 0.029 DBMET03173 0.063 0.029 DBMET03174 | DBMET03172 | |
| 0.029 | 0.016 | 0.047 | Lysine carboxypeptidase inhibitor | 0.047 0.008 DBMET03172 0.04 0.01 DBMET03173 0.043 0.009 DBMET03174 | DBMET03172 | |
| 0.048 | 0.036 | 0.061 | Bombesin 2 receptor antagonist | 0.061 0.024 DBMET03172 0.055 0.028 DBMET03173 0.056 0.027 DBMET03174 | DBMET03172 | |
| 0.036 | 0.024 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 DBMET03172 | DBMET03172 | |
| 0.028 | 0.015 | 0.033 | Thyroid hormone agonist | 0.033 0.01 DBMET03172 0.024 0.023 DBMET03174 | DBMET03172 | |
| 0.045 | 0.033 | 0.05 | Beta adrenoreceptor agonist | 0.046 0.027 DBMET03173 0.05 0.018 DBMET03174 | DBMET03174 | |
| 0.042 | 0.031 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 DBMET03172 0.062 0.01 DBMET03173 0.064 0.009 DBMET03174 | DBMET03172 | |
| 0.037 | 0.026 | 0.115 | 5-Alpha-reductase inhibitor | 0.115 0.009 DBMET03172 0.04 0.024 DBMET03173 0.037 0.026 DBMET03174 | DBMET03172 | |
| 0.076 | 0.066 | 0.076 | ErbB-3 antagonist | |||
| 0.041 | 0.031 | 0.085 | Leukocyte elastase inhibitor | 0.085 0.012 DBMET03172 | DBMET03172 | |
| 0.056 | 0.046 | 0.197 | Cathepsin E inhibitor | 0.197 0.004 DBMET03173 0.101 0.013 DBMET03174 | DBMET03173 | |
| 0.108 | 0.098 | 0.134 | Nav1.2 sodium channel blocker | 0.134 0.068 DBMET03172 0.105 0.103 DBMET03174 | DBMET03172 | |
| 0.034 | 0.024 | 0.052 | Angiotensin II receptor antagonist | 0.052 0.006 DBMET03172 0.032 0.029 DBMET03173 0.034 0.024 DBMET03174 | DBMET03172 | |
| 0.04 | 0.031 | 0.076 | Sphingosine kinase 1 inhibitor | 0.057 0.011 DBMET03172 0.076 0.005 DBMET03173 0.054 0.013 DBMET03174 | DBMET03173 | |
| 0.095 | 0.085 | 0.125 | Chelator | 0.125 0.049 DBMET03172 0.097 0.082 DBMET03174 | DBMET03172 | |
| 0.031 | 0.022 | 0.061 | Epoxide hydrolase 1 inhibitor | 0.061 0.004 DBMET03172 | DBMET03172 | |
| 0.047 | 0.038 | 0.068 | HCV NS3/NS4A protease inhibitor | 0.068 0.015 DBMET03172 0.045 0.043 DBMET03174 | DBMET03172 | |
| 0.042 | 0.034 | 0.064 | Glutamate (mGluR group III) antagonist | 0.064 0.011 DBMET03172 0.042 0.035 DBMET03173 0.042 0.034 DBMET03174 | DBMET03172 | |
| 0.027 | 0.018 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET03172 0.026 0.019 DBMET03173 0.028 0.015 DBMET03174 | DBMET03174 | |
| 0.037 | 0.029 | 0.062 | Retinoid X receptor antagonist | 0.062 0.005 DBMET03172 0.046 0.016 DBMET03173 0.044 0.018 DBMET03174 | DBMET03172 | |
| 0.018 | 0.01 | 0.037 | Ileal bile acid transport inhibitor | 0.037 0.004 DBMET03172 0.021 0.008 DBMET03173 0.021 0.009 DBMET03174 | DBMET03172 | |
| 0.032 | 0.024 | 0.04 | Carboxypeptidase B inhibitor | 0.04 0.012 DBMET03172 0.035 0.02 DBMET03173 0.037 0.016 DBMET03174 | DBMET03172 | |
| 0.026 | 0.018 | 0.04 | Acid ceramidase inhibitor | 0.04 0.004 DBMET03172 | DBMET03172 | |
| 0.061 | 0.054 | 0.085 | Calcium channel P-type blocker | 0.072 0.024 DBMET03172 0.076 0.019 DBMET03173 0.085 0.011 DBMET03174 | DBMET03174 | |
| 0.053 | 0.046 | 0.08 | Fatty acid synthase inhibitor | 0.08 0.019 DBMET03172 | DBMET03172 | |
| 0.05 | 0.043 | 0.05 | Human rhinovirus A protease inhibitor | |||
| 0.03 | 0.023 | 0.059 | Cholesterol ester transfer protein antagonist | 0.043 0.01 DBMET03172 0.052 0.006 DBMET03173 0.059 0.005 DBMET03174 | DBMET03174 | |
| 0.064 | 0.057 | 0.1 | MDM2 inhibitor | 0.09 0.011 DBMET03172 0.076 0.026 DBMET03173 0.1 0.007 DBMET03174 | DBMET03174 | |
| 0.021 | 0.014 | 0.034 | Retinoid X beta receptor antagonist | 0.034 0.004 DBMET03172 0.025 0.007 DBMET03173 0.025 0.007 DBMET03174 | DBMET03172 | |
| 0.05 | 0.044 | 0.05 | Maillard reaction inhibitor | 0.05 0.043 DBMET03172 | ||
| 0.056 | 0.05 | 0.269 | Purinergic P2X1 antagonist | 0.114 0.013 DBMET03172 0.11 0.014 DBMET03173 0.111 0.014 DBMET03174 0.269 0.002 DBMET03175 0.268 0.002 DBMET03176 0.214 0.003 DBMET03177 | DBMET03175 | |
| 0.017 | 0.011 | 0.026 | Telomerase stimulant | 0.025 0.004 DBMET03172 0.026 0.004 DBMET03173 0.026 0.004 DBMET03174 | DBMET03174 | |
| 0.031 | 0.025 | 0.072 | Prostacyclin antagonist | 0.072 0.007 DBMET03172 0.039 0.018 DBMET03174 | DBMET03172 | |
| 0.034 | 0.029 | 0.081 | Glutamate (mGluR3) antagonist | 0.081 0.005 DBMET03172 0.051 0.012 DBMET03173 0.062 0.008 DBMET03174 | DBMET03172 | |
| 0.025 | 0.019 | 0.179 | Leukotriene D4 antagonist | 0.179 0.004 DBMET03172 0.028 0.017 DBMET03173 0.029 0.016 DBMET03174 | DBMET03172 | |
| 0.019 | 0.014 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 DBMET03172 0.018 0.016 DBMET03174 | DBMET03172 | |
| 0.018 | 0.015 | 0.026 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET03172 0.02 0.012 DBMET03173 0.026 0.004 DBMET03174 | DBMET03174 | |
| 0.02 | 0.017 | 0.02 | Corticosteroid-like | |||
| 0.053 | 0.05 | 0.107 | Carbonic anhydrase stimulant | 0.107 0.017 DBMET03172 0.078 0.027 DBMET03173 0.075 0.029 DBMET03174 | DBMET03172 | |
| 0.072 | 0.069 | 0.098 | Adrenaline agonist | 0.087 0.048 DBMET03173 0.098 0.038 DBMET03174 | DBMET03174 | |
| 0.024 | 0.021 | 0.063 | Prostaglandin EP4 antagonist | 0.054 0.008 DBMET03172 0.063 0.007 DBMET03173 0.041 0.01 DBMET03174 | DBMET03173 | |
| 0.083 | 0.081 | 0.122 | ABCA1 expression enhancer | 0.097 0.054 DBMET03172 0.122 0.029 DBMET03173 0.103 0.046 DBMET03174 | DBMET03173 | |
| 0.006 | 0.005 | 0.01 | DNA polymerase III subunit alpha inhibitor | 0.01 0.003 DBMET03174 | DBMET03174 | |
| 0.031 | 0.03 | 0.052 | Retinoid X alpha receptor antagonist | 0.052 0.005 DBMET03172 0.041 0.014 DBMET03173 0.039 0.016 DBMET03174 | DBMET03172 | |
| 0.05 | 0.049 | 0.06 | Epithelial sodium channel blocker | 0.06 0.029 DBMET03172 | DBMET03172 | |
| 0.01 | 0.009 | 0.01 | Calcineurin inhibitor | |||
| 0.032 | 0.031 | 0.043 | Benzodiazepine receptor peripheral-type antagonist | 0.043 0.011 DBMET03172 | DBMET03172 | |
| 0.018 | 0.017 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | 0.021 0.015 DBMET03172 0.018 0.016 DBMET03173 | DBMET03172 | |
| 0.086 | 0.086 | 0.132 | Phosphodiesterase 6D inhibitor | 0.107 0.039 DBMET03172 0.132 0.017 DBMET03173 0.115 0.03 DBMET03174 | DBMET03173 | |
| 0.021 | 0.022 | 0.036 | Prostaglandin H2 antagonist | 0.036 0.008 DBMET03172 0.023 0.02 DBMET03174 | DBMET03172 | |
| 0.099 | 0.099 | 0.154 | Interleukin 8 antagonist | 0.154 0.031 DBMET03172 0.1 0.096 DBMET03173 | DBMET03172 | |
| 0.019 | 0.02 | 0.032 | Leukotriene B4 receptor 2 antagonist | 0.032 0.008 DBMET03172 0.023 0.014 DBMET03173 | DBMET03172 | |
| 0.022 | 0.024 | 0.057 | Glutamate (mGluR1) agonist | 0.057 0.004 DBMET03172 0.03 0.01 DBMET03173 0.034 0.008 DBMET03174 | DBMET03172 | |
| 0.045 | 0.047 | 0.06 | CD45 antagonist | 0.06 0.022 DBMET03172 0.05 0.035 DBMET03174 | DBMET03172 | |
| 0.02 | 0.022 | 0.021 | Retinoic acid receptor agonist | 0.021 0.02 DBMET03172 | DBMET03172 | |
| 0.037 | 0.039 | 0.044 | Plasmepsin II inhibitor | 0.042 0.027 DBMET03172 0.044 0.024 DBMET03173 0.041 0.028 DBMET03174 | DBMET03173 | |
| 0.008 | 0.013 | 0.013 | Angiotensin AT2 receptor agonist | 0.013 0.005 DBMET03172 | DBMET03172 | |
| 0.044 | 0.05 | 0.143 | Cathepsin D inhibitor | 0.143 0.008 DBMET03173 0.118 0.013 DBMET03174 | DBMET03173 | |
| 0.043 | 0.049 | 0.062 | Prolyl endopeptidase inhibitor | 0.062 0.022 DBMET03172 | DBMET03172 | |
| 0.022 | 0.028 | 0.046 | Nicotinic acid receptor 2 antagonist | 0.046 0.004 DBMET03172 0.031 0.011 DBMET03173 0.03 0.013 DBMET03174 | DBMET03172 | |
| 0.012 | 0.019 | 0.024 | G-protein-coupled receptor 120 agonist | 0.024 0.007 DBMET03172 0.021 0.009 DBMET03173 0.019 0.01 DBMET03174 | DBMET03172 | |
| 0.029 | 0.036 | 0.068 | Nicotinic acid receptor agonist | 0.068 0.009 DBMET03172 0.06 0.011 DBMET03173 0.043 0.019 DBMET03174 | DBMET03172 | |
| 0.051 | 0.058 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.063 0.018 DBMET03172 0.066 0.015 DBMET03173 0.076 0.008 DBMET03174 | DBMET03174 | |
| 0.019 | 0.026 | 0.029 | Vitamin D receptor antagonist | 0.029 0.008 DBMET03174 | DBMET03174 | |
| 0.09 | 0.098 | 0.158 | DOPA decarboxylase inhibitor | 0.158 0.017 DBMET03172 0.142 0.026 DBMET03173 0.153 0.02 DBMET03174 | DBMET03172 | |
| 0.031 | 0.039 | 0.058 | Cholecystokinin B agonist | 0.058 0.013 DBMET03172 | DBMET03172 | |
| 0.037 | 0.045 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.025 DBMET03172 | DBMET03172 | |
| 0.033 | 0.041 | 0.053 | Glutamate (mGluR1a) antagonist | 0.053 0.019 DBMET03172 0.042 0.027 DBMET03174 | DBMET03172 | |
| 0.008 | 0.017 | 0.021 | Glutamate (mGluR6) agonist | 0.021 0.004 DBMET03172 0.016 0.005 DBMET03173 0.019 0.004 DBMET03174 | DBMET03172 | |
| 0.038 | 0.047 | 0.058 | Dihydrofolate reductase inhibitor | 0.058 0.012 DBMET03172 | DBMET03172 | |
| 0.033 | 0.042 | 0.037 | Growth hormone release inhibitor | 0.037 0.035 DBMET03174 | DBMET03174 | |
| 0.038 | 0.047 | 0.063 | Cannabinoid CB2 receptor antagonist | 0.063 0.028 DBMET03172 | DBMET03172 | |
| 0.046 | 0.056 | 0.071 | Heparanase inhibitor | 0.071 0.011 DBMET03172 0.056 0.03 DBMET03173 0.058 0.027 DBMET03174 | DBMET03172 | |
| 0.023 | 0.033 | 0.064 | Peptide deformylase inhibitor | 0.064 0.006 DBMET03172 | DBMET03172 | |
| 0.012 | 0.022 | 0.024 | Aminopeptidase A inhibitor | 0.024 0.008 DBMET03172 0.021 0.01 DBMET03173 0.023 0.009 DBMET03174 | DBMET03172 | |
| 0.067 | 0.078 | 0.084 | Chymotrypsin inhibitor | 0.084 0.05 DBMET03172 | DBMET03172 | |
| 0.034 | 0.044 | 0.039 | Neurokinin 2 agonist | 0.039 0.032 DBMET03172 | DBMET03172 | |
| 0.029 | 0.04 | 0.036 | Factor XIIIa inhibitor | 0.036 0.027 DBMET03172 | DBMET03172 | |
| 0.059 | 0.071 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.056 DBMET03172 | DBMET03172 | |
| 0.036 | 0.048 | 0.061 | AICAR transformylase inhibitor | 0.061 0.014 DBMET03172 0.046 0.027 DBMET03173 0.051 0.021 DBMET03174 0.054 0.019 DBMET03175 0.048 0.024 DBMET03176 | DBMET03172 | |
| 0.015 | 0.027 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DBMET03172 | DBMET03172 | |
| 0.082 | 0.094 | 0.127 | Interleukin 12 antagonist | 0.103 0.048 DBMET03172 0.127 0.023 DBMET03174 | DBMET03174 | |
| 0.024 | 0.037 | 0.027 | DNA polymerase III inhibitor | 0.027 0.023 DBMET03174 | DBMET03174 | |
| 0.03 | 0.043 | 0.054 | Delayed rectifier potassium channel blocker | 0.054 0.009 DBMET03172 | DBMET03172 | |
| 0.082 | 0.095 | 0.111 | Nav1.1 sodium channel blocker | 0.111 0.055 DBMET03174 | DBMET03174 | |
| 0.032 | 0.045 | 0.057 | Carbonic anhydrase IV inhibitor | 0.057 0.021 DBMET03172 | DBMET03172 | |
| 0.028 | 0.041 | 0.055 | Farnesoid X receptor agonist | 0.044 0.019 DBMET03172 0.042 0.021 DBMET03173 0.055 0.012 DBMET03174 | DBMET03174 | |
| 0.158 | 0.172 | 0.302 | Peptidyltransferase inhibitor | 0.169 0.148 DBMET03172 0.269 0.039 DBMET03173 0.302 0.024 DBMET03174 0.219 0.077 DBMET03175 0.219 0.078 DBMET03176 0.219 0.078 DBMET03177 | DBMET03174 | |
| 0.004 | 0.018 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 DBMET03173 0.015 0.003 DBMET03174 | DBMET03174 | |
| 0.046 | 0.061 | 0.082 | Glucagon-like peptide 1 agonist | 0.081 0.034 DBMET03172 0.06 0.048 DBMET03173 0.082 0.034 DBMET03174 | DBMET03174 | |
| 0.059 | 0.074 | 0.158 | Antineoplastic antibiotic | 0.107 0.043 DBMET03173 0.158 0.029 DBMET03174 | DBMET03174 | |
| 0.114 | 0.129 | 0.169 | Hexokinase inhibitor | 0.147 0.082 DBMET03172 0.134 0.099 DBMET03173 0.169 0.059 DBMET03174 0.165 0.062 DBMET03175 0.159 0.068 DBMET03176 | DBMET03174 | |
| 0.007 | 0.022 | 0.019 | Angiotensin AT1B receptor antagonist | 0.019 0.006 DBMET03172 | DBMET03172 | |
| 0.021 | 0.037 | 0.049 | Plasmepsin I inhibitor | 0.049 0.008 DBMET03173 0.048 0.008 DBMET03174 | DBMET03173 | |
| 0.037 | 0.052 | 0.059 | Metalloproteinase-3 inhibitor | 0.059 0.025 DBMET03172 | DBMET03172 | |
| 0.025 | 0.041 | 0.071 | Retinoid X alpha receptor agonist | 0.071 0.009 DBMET03172 0.046 0.016 DBMET03173 0.051 0.014 DBMET03174 | DBMET03172 | |
| 0.033 | 0.05 | 0.062 | HIV-1 protease inhibitor | 0.062 0.011 DBMET03173 0.055 0.016 DBMET03174 | DBMET03173 | |
| 0.007 | 0.024 | 0.049 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.049 0.004 DBMET03172 | DBMET03172 | |
| 0.026 | 0.043 | 0.038 | G protein-coupled receptor agonist | 0.038 0.027 DBMET03172 0.033 0.032 DBMET03173 | DBMET03172 | |
| 0.022 | 0.039 | 0.062 | Renin inhibitor | 0.062 0.012 DBMET03173 0.061 0.013 DBMET03174 | DBMET03173 | |
| 0.05 | 0.068 | 0.136 | NMDA receptor agonist | 0.136 0.01 DBMET03172 0.074 0.033 DBMET03173 0.091 0.023 DBMET03174 | DBMET03172 | |
| 0.02 | 0.038 | 0.037 | Acetylcholine M4 receptor agonist | 0.037 0.016 DBMET03172 | DBMET03172 | |
| 0.038 | 0.057 | 0.044 | Heme oxygenase inhibitor | 0.044 0.024 DBMET03172 0.042 0.032 DBMET03173 0.044 0.025 DBMET03174 | DBMET03174 | |
| 0.01 | 0.03 | 0.103 | Purinergic P2T antagonist | 0.056 0.009 DBMET03172 0.101 0.005 DBMET03175 0.103 0.005 DBMET03176 0.09 0.005 DBMET03177 | DBMET03176 | |
| 0.008 | 0.028 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.021 0.004 DBMET03172 | DBMET03172 | |
| 0.034 | 0.054 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.063 0.006 DBMET03172 0.054 0.011 DBMET03173 0.055 0.01 DBMET03174 | DBMET03172 | |
| 0.026 | 0.046 | 0.08 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.03 DBMET03174 0.08 0.007 DBMET03175 0.068 0.009 DBMET03176 0.035 0.026 DBMET03177 | DBMET03175 | |
| 0.015 | 0.035 | 0.069 | Glutamate (mGluR1a) agonist | 0.069 0.004 DBMET03172 0.021 0.017 DBMET03173 0.023 0.014 DBMET03174 | DBMET03172 | |
| 0.007 | 0.028 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET03175 0.011 0.009 DBMET03176 | DBMET03175 | |
| 0.028 | 0.05 | 0.062 | Oxytocin agonist | 0.062 0.015 DBMET03172 | DBMET03172 | |
| 0.024 | 0.046 | 0.05 | Free fatty acid receptor 1 antagonist | 0.05 0.009 DBMET03172 0.038 0.018 DBMET03173 0.036 0.02 DBMET03174 | DBMET03172 | |
| 0.018 | 0.041 | 0.054 | Sphingosine 1-phosphate receptor 3 agonist | 0.029 0.028 DBMET03172 0.05 0.016 DBMET03173 0.054 0.014 DBMET03174 | DBMET03174 | |
| 0.055 | 0.077 | 0.062 | Beta 2 adrenoreceptor agonist | 0.061 0.046 DBMET03172 0.062 0.042 DBMET03173 0.062 0.042 DBMET03174 | DBMET03174 | |
| 0.042 | 0.065 | 0.058 | Matrix metalloproteinase (membrane-type) inhibitor | 0.058 0.034 DBMET03172 | DBMET03172 | |
| 0.097 | 0.119 | 0.122 | NADPH oxidase inhibitor | 0.122 0.081 DBMET03172 | DBMET03172 | |
| 0.039 | 0.062 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.065 0.011 DBMET03172 0.05 0.03 DBMET03173 0.056 0.02 DBMET03174 | DBMET03172 | |
| 0.016 | 0.039 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.018 DBMET03172 | DBMET03172 | |
| 0.114 | 0.138 | 0.137 | Neuropeptide Y1 antagonist | 0.137 0.086 DBMET03172 | DBMET03172 | |
| 0.012 | 0.036 | 0.036 | 5-Alpha-reductase 2 inhibitor | 0.036 0.008 DBMET03172 | DBMET03172 | |
| 0.089 | 0.113 | 0.122 | Cholinergic antagonist | 0.122 0.072 DBMET03172 | DBMET03172 | |
| 0.022 | 0.046 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET03172 | DBMET03172 | |
| 0.02 | 0.045 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET03173 0.026 0.018 DBMET03174 | DBMET03174 | |
| 0.018 | 0.043 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET03174 | DBMET03174 | |
| 0.068 | 0.094 | 0.1 | Caspase 7 inhibitor | 0.1 0.028 DBMET03172 | DBMET03172 | |
| 0.1 | 0.125 | 0.129 | Interleukin 1 antagonist | 0.129 0.076 DBMET03174 | DBMET03174 | |
| 0.02 | 0.046 | 0.086 | Leukotriene A4 hydrolase inhibitor | 0.086 0.007 DBMET03172 | DBMET03172 | |
| 0.029 | 0.056 | 0.103 | Phosphorylase inhibitor | 0.083 0.016 DBMET03173 0.083 0.016 DBMET03174 0.103 0.013 DBMET03175 0.091 0.014 DBMET03176 0.051 0.03 DBMET03177 | DBMET03175 | |
| 0.084 | 0.112 | 0.109 | Acetylcholine muscarinic antagonist | 0.109 0.08 DBMET03172 | DBMET03172 | |
| 0.027 | 0.056 | 0.075 | Dopamine D5 agonist | 0.075 0.007 DBMET03172 0.054 0.015 DBMET03173 0.05 0.018 DBMET03174 | DBMET03172 | |
| 0.006 | 0.035 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 DBMET03175 0.013 0.004 DBMET03176 0.012 0.005 DBMET03177 | DBMET03175 | |
| 0.028 | 0.057 | 0.054 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET03172 0.039 0.019 DBMET03173 0.039 0.019 DBMET03174 | DBMET03172 | |
| 0.004 | 0.033 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 DBMET03172 | DBMET03172 | |
| 0.072 | 0.102 | 0.17 | DNA directed RNA polymerase inhibitor | 0.17 0.019 DBMET03175 0.167 0.019 DBMET03176 0.154 0.023 DBMET03177 | DBMET03175 | |
| 0.037 | 0.068 | 0.054 | Acetylcholine muscarinic agonist | 0.054 0.039 DBMET03172 | DBMET03172 | |
| 0.007 | 0.038 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET03174 | DBMET03174 | |
| 0.027 | 0.059 | 0.052 | GP IIb/IIIa receptor antagonist | 0.052 0.031 DBMET03172 | DBMET03172 | |
| 0.047 | 0.079 | 0.11 | CDC25B inhibitor | 0.11 0.013 DBMET03172 | DBMET03172 | |
| 0.024 | 0.056 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.022 DBMET03172 0.035 0.02 DBMET03173 0.038 0.016 DBMET03174 | DBMET03174 | |
| 0.014 | 0.046 | 0.021 | Beta 1 adrenoreceptor agonist | 0.021 0.018 DBMET03174 | DBMET03174 | |
| 0.012 | 0.046 | 0.025 | Angiotensin AT1A receptor antagonist | 0.025 0.01 DBMET03172 | DBMET03172 | |
| 0.008 | 0.042 | 0.068 | 5-Alpha-reductase 1 inhibitor | 0.068 0.006 DBMET03172 | DBMET03172 | |
| 0.16 | 0.194 | 0.22 | 12-Lipoxygenase inhibitor | 0.22 0.13 DBMET03172 | DBMET03172 | |
| 0.013 | 0.048 | 0.041 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 DBMET03172 0.027 0.018 DBMET03173 0.041 0.009 DBMET03174 | DBMET03174 | |
| 0.048 | 0.083 | 0.094 | Corticotropin releasing factor 2 receptor antagonist | 0.094 0.009 DBMET03172 | DBMET03172 | |
| 0.025 | 0.061 | 0.056 | Dihydropteroate synthase inhibitor | 0.056 0.013 DBMET03172 | DBMET03172 | |
| 0.021 | 0.058 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 DBMET03172 0.027 0.022 DBMET03173 0.028 0.021 DBMET03174 | DBMET03172 | |
| 0.108 | 0.146 | 0.194 | Dual specificity phosphatase 3 inhibitor | 0.194 0.064 DBMET03172 | DBMET03172 | |
| 0.042 | 0.08 | 0.062 | Matrix metalloproteinase inhibitor | 0.062 0.051 DBMET03172 | DBMET03172 | |
| 0.083 | 0.121 | 0.116 | Acetylcholine antagonist | 0.116 0.074 DBMET03172 | DBMET03172 | |
| 0.042 | 0.081 | 0.06 | Cannabinoid CB1 receptor antagonist | 0.06 0.045 DBMET03172 | DBMET03172 | |
| 0.064 | 0.104 | 0.18 | 5-Lipoxygenase inhibitor | 0.18 0.029 DBMET03172 | DBMET03172 | |
| 0.027 | 0.067 | 0.044 | Adenosine uptake inhibitor | 0.044 0.007 DBMET03172 | DBMET03172 | |
| 0.04 | 0.082 | 0.076 | Nicotinic alpha3beta2 receptor antagonist | 0.076 0.014 DBMET03172 | DBMET03172 | |
| 0.028 | 0.071 | 0.064 | Potassium channel Kv1.3 blocker | 0.064 0.018 DBMET03172 | DBMET03172 | |
| 0.015 | 0.058 | 0.039 | Sirtuin 2 inhibitor | 0.039 0.018 DBMET03172 | DBMET03172 | |
| 0.008 | 0.051 | 0.047 | Angiotensin AT2 receptor antagonist | 0.047 0.01 DBMET03172 | DBMET03172 | |
| 0.023 | 0.067 | 0.039 | Melatonin receptor 1A agonist | 0.039 0.014 DBMET03172 | DBMET03172 | |
| 0.008 | 0.053 | 0.027 | Thyroid hormone alpha antagonist | 0.027 0.005 DBMET03172 | DBMET03172 | |
| 0.057 | 0.102 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.017 DBMET03172 0.073 0.053 DBMET03173 0.073 0.052 DBMET03174 | DBMET03172 | |
| 0.068 | 0.114 | 0.163 | Falcipain 3 inhibitor | 0.163 0.031 DBMET03172 0.097 0.073 DBMET03173 0.098 0.072 DBMET03174 | DBMET03172 | |
| 0.036 | 0.083 | 0.055 | Cannabinoid receptor agonist | 0.055 0.053 DBMET03172 | DBMET03172 | |
| 0.048 | 0.095 | 0.08 | Acetylcholine M4 receptor antagonist | 0.08 0.046 DBMET03172 | DBMET03172 | |
| 0.013 | 0.06 | 0.033 | Prostaglandin EP3 antagonist | 0.031 0.02 DBMET03172 0.033 0.018 DBMET03173 | DBMET03173 | |
| 0.078 | 0.125 | 0.12 | Glutamate (mGluR7) agonist | 0.12 0.03 DBMET03172 0.092 0.078 DBMET03174 | DBMET03172 | |
| 0.068 | 0.117 | 0.103 | D-Ala-D-Ala ligase inhibitor | 0.103 0.025 DBMET03172 0.089 0.047 DBMET03173 0.091 0.043 DBMET03174 | DBMET03172 | |
| 0.003 | 0.053 | 0.069 | Purinergic P2Y agonist | 0.069 0.002 DBMET03175 0.068 0.002 DBMET03176 0.064 0.002 DBMET03177 | DBMET03175 | |
| 0.034 | 0.084 | 0.055 | 5 Hydroxytryptamine 4 antagonist | 0.055 0.03 DBMET03172 | DBMET03172 | |
| 0.053 | 0.105 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.058 DBMET03172 | DBMET03172 | |
| 0.109 | 0.161 | 0.199 | Dual specificity phosphatase inhibitor | 0.199 0.055 DBMET03172 | DBMET03172 | |
| 0.003 | 0.055 | 0.079 | Purinergic P2 agonist | 0.079 0.002 DBMET03175 0.078 0.002 DBMET03176 0.074 0.002 DBMET03177 | DBMET03175 | |
| 0.003 | 0.055 | 0.079 | Purinergic receptor agonist | 0.079 0.002 DBMET03175 0.078 0.002 DBMET03176 0.074 0.002 DBMET03177 | DBMET03175 | |
| 0.028 | 0.079 | 0.057 | Dihydroorotase inhibitor | 0.057 0.019 DBMET03172 | DBMET03172 | |
| 0.035 | 0.086 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 DBMET03172 0.06 0.03 DBMET03173 0.077 0.018 DBMET03174 | DBMET03174 | |
| 0.029 | 0.083 | 0.055 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET03173 0.054 0.036 DBMET03175 0.054 0.036 DBMET03176 0.055 0.035 DBMET03177 | DBMET03177 | |
| 0.024 | 0.078 | 0.035 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET03173 0.035 0.028 DBMET03174 0.033 0.031 DBMET03175 0.033 0.032 DBMET03176 0.034 0.029 DBMET03177 | DBMET03174 | |
| 0.018 | 0.073 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET03172 | DBMET03172 | |
| 0.025 | 0.08 | 0.066 | Histamine H2 receptor agonist | 0.066 0.012 DBMET03172 | DBMET03172 | |
| 0.026 | 0.081 | 0.091 | AMPA 4 receptor antagonist | 0.091 0.005 DBMET03172 0.038 0.031 DBMET03173 | DBMET03172 | |
| 0.019 | 0.074 | 0.047 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 DBMET03172 0.033 0.024 DBMET03173 0.033 0.025 DBMET03174 0.035 0.022 DBMET03176 | DBMET03172 | |
| 0.052 | 0.107 | 0.077 | Metalloproteinase-2 inhibitor | 0.077 0.055 DBMET03172 | DBMET03172 | |
| 0.019 | 0.075 | 0.045 | Carnitine palmitoyltransferase 1 inhibitor | 0.045 0.01 DBMET03172 0.033 0.024 DBMET03173 0.033 0.025 DBMET03174 0.032 0.028 DBMET03176 | DBMET03172 | |
| 0.058 | 0.115 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.107 0.031 DBMET03172 | DBMET03172 | |
| 0.029 | 0.086 | 0.042 | Glucagon-like peptide 1 receptor antagonist | 0.042 0.022 DBMET03172 0.037 0.035 DBMET03174 | DBMET03172 | |
| 0.003 | 0.06 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET03172 | DBMET03172 | |
| 0.042 | 0.1 | 0.064 | Cannabinoid receptor antagonist | 0.064 0.057 DBMET03172 | DBMET03172 | |
| 0.072 | 0.13 | 0.136 | Carbonic anhydrase XV inhibitor | 0.136 0.037 DBMET03172 0.091 0.081 DBMET03173 0.095 0.075 DBMET03174 | DBMET03172 | |
| 0.054 | 0.113 | 0.087 | Potassium channel (Ca-activated) activator | 0.087 0.067 DBMET03172 | DBMET03172 | |
| 0.014 | 0.072 | 0.084 | Kainate receptor 2 antagonist | 0.084 0.006 DBMET03172 | DBMET03172 | |
| 0.151 | 0.21 | 0.224 | Thyroid hormone antagonist | 0.224 0.142 DBMET03172 | DBMET03172 | |
| 0.013 | 0.073 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET03172 0.021 0.015 DBMET03173 0.022 0.011 DBMET03174 | DBMET03174 | |
| 0.058 | 0.118 | 0.08 | Estrogen receptor alpha antagonist | 0.08 0.049 DBMET03172 | DBMET03172 | |
| 0.054 | 0.114 | 0.075 | Phosphodiesterase VI inhibitor | 0.075 0.05 DBMET03173 | DBMET03173 | |
| 0.02 | 0.082 | 0.118 | Macrophage elastase inhibitor | 0.038 0.036 DBMET03172 0.118 0.007 DBMET03173 0.073 0.014 DBMET03174 | DBMET03173 | |
| 0.064 | 0.127 | 0.097 | mTOR complex 2 inhibitor | 0.097 0.037 DBMET03172 0.077 0.076 DBMET03173 0.079 0.072 DBMET03174 | DBMET03172 | |
| 0.016 | 0.079 | 0.03 | Retinoid X gamma receptor antagonist | 0.03 0.013 DBMET03172 | DBMET03172 | |
| 0.031 | 0.095 | 0.069 | Elastase inhibitor | 0.069 0.023 DBMET03172 | DBMET03172 | |
| 0.058 | 0.123 | 0.098 | Histamine H2 receptor antagonist | 0.098 0.036 DBMET03172 | DBMET03172 | |
| 0.047 | 0.112 | 0.112 | CYP2A6 inhibitor | 0.112 0.03 DBMET03172 | DBMET03172 | |
| 0.011 | 0.077 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.012 DBMET03172 | DBMET03172 | |
| 0.145 | 0.211 | 0.209 | Thyroid hormone beta antagonist | 0.209 0.147 DBMET03172 | DBMET03172 | |
| 0.031 | 0.1 | 0.097 | NMDA receptor glycine site agonist | 0.097 0.018 DBMET03172 0.064 0.042 DBMET03173 0.08 0.029 DBMET03174 | DBMET03172 | |
| 0.044 | 0.112 | 0.089 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.089 0.044 DBMET03172 0.073 0.057 DBMET03173 0.081 0.05 DBMET03174 | DBMET03172 | |
| 0.036 | 0.105 | 0.062 | Botulinum neurotoxin type A inhibitor | 0.055 0.045 DBMET03172 0.062 0.034 DBMET03174 | DBMET03174 | |
| 0.017 | 0.088 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET03172 | DBMET03172 | |
| 0.055 | 0.127 | 0.078 | Antineoplastic alkaloid | 0.078 0.068 DBMET03172 | DBMET03172 | |
| 0.01 | 0.083 | 0.038 | Glucagon receptor antagonist | 0.038 0.015 DBMET03172 | DBMET03172 | |
| 0.049 | 0.124 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.046 DBMET03172 | DBMET03172 | |
| 0.004 | 0.08 | 0.036 | Kainate receptor 1 antagonist | 0.036 0.008 DBMET03172 | DBMET03172 | |
| 0.046 | 0.123 | 0.068 | Secretase beta inhibitor | 0.068 0.053 DBMET03174 | DBMET03174 | |
| 0.07 | 0.147 | 0.13 | Nav1.4 sodium channel blocker | 0.13 0.044 DBMET03172 | DBMET03172 | |
| 0.029 | 0.106 | 0.073 | Neutrophil collagenase inhibitor | 0.073 0.037 DBMET03172 0.057 0.055 DBMET03174 | DBMET03172 | |
| 0.023 | 0.103 | 0.103 | Neuropeptide agonist | 0.103 0.026 DBMET03174 | DBMET03174 | |
| 0.029 | 0.109 | 0.078 | Aldosterone antagonist | 0.065 0.016 DBMET03172 0.058 0.021 DBMET03173 0.078 0.011 DBMET03174 | DBMET03174 | |
| 0.01 | 0.09 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DBMET03172 | DBMET03172 | |
| 0.019 | 0.099 | 0.1 | Endothelin-converting enzyme inhibitor | 0.05 0.03 DBMET03173 0.1 0.014 DBMET03174 | DBMET03174 | |
| 0.007 | 0.088 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 DBMET03172 | DBMET03172 | |
| 0.021 | 0.103 | 0.069 | Thymidylate synthase inhibitor | 0.069 0.012 DBMET03172 0.046 0.034 DBMET03174 | DBMET03172 | |
| 0.104 | 0.188 | 0.161 | Pregnane X receptor agonist | 0.161 0.036 DBMET03172 0.125 0.115 DBMET03174 | DBMET03172 | |
| 0.01 | 0.094 | 0.025 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.011 DBMET03172 | DBMET03172 | |
| 0.046 | 0.132 | 0.068 | Histone deacetylase SIRT3 inhibitor | 0.068 0.03 DBMET03172 | DBMET03172 | |
| 0.054 | 0.141 | 0.145 | HIV-1 integrase (Overall Integration) inhibitor | 0.145 0.027 DBMET03172 0.12 0.04 DBMET03173 0.136 0.031 DBMET03174 | DBMET03172 | |
| 0.013 | 0.101 | 0.061 | Kainate receptor antagonist | 0.061 0.015 DBMET03172 | DBMET03172 | |
| 0.09 | 0.178 | 0.232 | Mannose-6-phosphate isomerase inhibitor | 0.139 0.075 DBMET03172 0.212 0.024 DBMET03173 0.232 0.017 DBMET03174 | DBMET03174 | |
| 0.029 | 0.118 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.018 DBMET03172 | DBMET03172 | |
| 0.011 | 0.099 | 0.034 | Liver X receptor beta antagonist | 0.034 0.016 DBMET03172 | DBMET03172 | |
| 0.031 | 0.12 | 0.061 | Potassium channel (Inward rectifier) activator | 0.061 0.019 DBMET03172 | DBMET03172 | |
| 0.007 | 0.097 | 0.024 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.024 0.005 DBMET03175 0.023 0.005 DBMET03176 0.022 0.006 DBMET03177 | DBMET03175 | |
| 0.051 | 0.141 | 0.107 | Urease inhibitor | 0.107 0.058 DBMET03172 | DBMET03172 | |
| 0.007 | 0.1 | 0.027 | Aminopeptidase P inhibitor | 0.024 0.015 DBMET03173 0.027 0.013 DBMET03174 | DBMET03174 | |
| 0.009 | 0.103 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET03172 | DBMET03172 | |
| 0.075 | 0.171 | 0.1 | Factor V inhibitor | 0.1 0.069 DBMET03172 0.093 0.088 DBMET03174 | DBMET03172 | |
| 0.008 | 0.103 | 0.064 | Adenosine A1 receptor agonist | 0.064 0.005 DBMET03175 0.063 0.005 DBMET03176 0.056 0.005 DBMET03177 | DBMET03175 | |
| 0.019 | 0.115 | 0.056 | p53 inhibitor | 0.054 0.012 DBMET03173 0.056 0.01 DBMET03174 | DBMET03174 | |
| 0.022 | 0.119 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 DBMET03172 | DBMET03172 | |
| 0.019 | 0.116 | 0.081 | Prostaglandin antagonist | 0.081 0.022 DBMET03172 0.05 0.04 DBMET03173 | DBMET03172 | |
| 0.006 | 0.103 | 0.029 | Cholecystokinin agonist | 0.029 0.01 DBMET03172 | DBMET03172 | |
| 0.017 | 0.115 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 DBMET03172 | DBMET03172 | |
| 0.016 | 0.115 | 0.028 | Complement factor 1s inhibitor | 0.028 0.011 DBMET03172 | DBMET03172 | |
| 0.005 | 0.107 | 0.02 | Human T-cell leukemia virus type I protease inhibitor | 0.02 0.016 DBMET03174 | DBMET03174 | |
| 0.044 | 0.147 | 0.113 | Histamine N-methyltransferase inhibitor | 0.113 0.035 DBMET03172 | DBMET03172 | |
| 0.004 | 0.107 | 0.032 | Free fatty acid receptor 1 agonist | 0.025 0.008 DBMET03172 0.032 0.006 DBMET03174 | DBMET03174 | |
| 0.02 | 0.125 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.018 DBMET03174 | DBMET03174 | |
| 0.021 | 0.129 | 0.04 | Histone deacetylase 9 inhibitor | 0.04 0.025 DBMET03172 | DBMET03172 | |
| 0.008 | 0.116 | 0.025 | Retinoid X gamma receptor agonist | 0.025 0.014 DBMET03172 | DBMET03172 | |
| 0.016 | 0.126 | 0.033 | Dipeptidyl peptidase II inhibitor | 0.033 0.022 DBMET03172 | DBMET03172 | |
| 0.028 | 0.14 | 0.055 | Collagenase 3 inhibitor | 0.053 0.052 DBMET03172 0.055 0.049 DBMET03173 | DBMET03173 | |
| 0.034 | 0.146 | 0.101 | Nicotinic alpha4beta2 receptor antagonist | 0.101 0.03 DBMET03172 | DBMET03172 | |
| 0.023 | 0.137 | 0.053 | Histamine H1 receptor agonist | 0.053 0.015 DBMET03172 | DBMET03172 | |
| 0.102 | 0.218 | 0.167 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.096 DBMET03172 0.167 0.077 DBMET03174 | DBMET03174 | |
| 0.044 | 0.163 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.036 DBMET03172 | DBMET03172 | |
| 0.004 | 0.123 | 0.038 | AMPA 1 receptor antagonist | 0.038 0.016 DBMET03172 | DBMET03172 | |
| 0.006 | 0.125 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 DBMET03172 | DBMET03172 | |
| 0.019 | 0.138 | 0.074 | NMDA 2C receptor antagonist | 0.074 0.03 DBMET03172 | DBMET03172 | |
| 0.014 | 0.134 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.022 DBMET03175 0.034 0.027 DBMET03176 0.032 0.031 DBMET03177 | DBMET03175 | |
| 0.007 | 0.129 | 0.133 | Purinergic P2X agonist | 0.133 0.002 DBMET03175 0.13 0.002 DBMET03176 0.123 0.003 DBMET03177 | DBMET03175 | |
| 0.006 | 0.129 | 0.078 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.078 0.003 DBMET03175 0.076 0.003 DBMET03176 0.071 0.003 DBMET03177 | DBMET03175 | |
| 0.049 | 0.173 | 0.395 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 DBMET03173 0.11 0.036 DBMET03174 0.395 0.004 DBMET03175 0.393 0.004 DBMET03176 0.377 0.004 DBMET03177 | DBMET03175 | |
| 0.024 | 0.149 | 0.057 | TRPA1 antagonist | 0.057 0.048 DBMET03172 | DBMET03172 | |
| 0.01 | 0.135 | 0.064 | Urate transporter 1 inhibitor | 0.064 0.013 DBMET03172 0.035 0.032 DBMET03173 0.04 0.026 DBMET03174 | DBMET03172 | |
| 0 | 0.131 | 0.008 | Purinergic P2Y4 agonist | 0.008 0.002 DBMET03175 0.008 0.002 DBMET03176 0.007 0.002 DBMET03177 | DBMET03176 | |
| 0.026 | 0.159 | 0.061 | HIV-1 reverse transcriptase inhibitor | 0.061 0.057 DBMET03175 0.06 0.058 DBMET03176 | DBMET03175 | |
| 0.004 | 0.142 | 0.022 | Integrin alpha4 antagonist | 0.022 0.019 DBMET03172 | DBMET03172 | |
| 0.005 | 0.146 | 0.036 | Cholecystokinin A antagonist | 0.036 0.027 DBMET03172 | DBMET03172 | |
| 0.034 | 0.176 | 0.063 | Phosphodiesterase 1A inhibitor | 0.063 0.034 DBMET03172 | DBMET03172 | |
| 0.013 | 0.155 | 0.053 | NMDA 2A receptor antagonist | 0.053 0.035 DBMET03172 | DBMET03172 | |
| 0.007 | 0.153 | 0.058 | Cholecystokinin antagonist | 0.058 0.02 DBMET03172 | DBMET03172 | |
| 0.011 | 0.161 | 0.037 | NMDA receptor subunit 3A antagonist | 0.037 0.028 DBMET03172 | DBMET03172 | |
| 0.059 | 0.21 | 0.094 | CC chemokine 5 receptor agonist | 0.094 0.03 DBMET03172 | DBMET03172 | |
| 0.028 | 0.179 | 0.047 | Carbonic anhydrase II stimulant | 0.047 0.046 DBMET03172 | DBMET03172 | |
| 0.051 | 0.202 | 0.079 | MAP kinase kinase 7 inhibitor | 0.077 0.054 DBMET03172 0.079 0.05 DBMET03174 | DBMET03174 | |
| 0.017 | 0.169 | 0.036 | MAP3K5 inhibitor | 0.036 0.034 DBMET03172 | DBMET03172 | |
| 0.016 | 0.171 | 0.05 | NMDA receptor subunit 3B antagonist | 0.05 0.025 DBMET03172 | DBMET03172 | |
| 0.031 | 0.186 | 0.066 | Potassium channel (ATP-sensitive) blocker | 0.066 0.048 DBMET03172 | DBMET03172 | |
| 0.077 | 0.234 | 0.124 | Sphingosine 1-phosphate receptor 2 agonist | 0.124 0.048 DBMET03174 | DBMET03174 | |
| 0.02 | 0.182 | 0.065 | Prostaglandin-E synthase inhibitor | 0.065 0.056 DBMET03172 | DBMET03172 | |
| 0.065 | 0.228 | 0.171 | Histone deacetylase SIRT1 inhibitor | 0.171 0.045 DBMET03172 | DBMET03172 | |
| 0.019 | 0.186 | 0.038 | Potassium channel Kv1.1 blocker | 0.038 0.026 DBMET03172 | DBMET03172 | |
| 0.043 | 0.212 | 0.144 | Uric acid excretion stimulant | 0.121 0.037 DBMET03172 0.144 0.025 DBMET03173 0.136 0.029 DBMET03174 | DBMET03173 | |
| 0.036 | 0.207 | 0.063 | Phosphodiesterase 1C inhibitor | 0.063 0.041 DBMET03172 | DBMET03172 | |
| 0.009 | 0.182 | 0.036 | Integrin antagonist | 0.036 0.033 DBMET03172 | DBMET03172 | |
| 0.028 | 0.203 | 0.056 | Dihydroorotate oxidase inhibitor | 0.056 0.037 DBMET03172 0.051 0.048 DBMET03173 0.056 0.036 DBMET03174 | DBMET03174 | |
| 0.127 | 0.306 | 0.26 | 15-Lipoxygenase inhibitor | 0.26 0.157 DBMET03172 | DBMET03172 | |
| 0.024 | 0.209 | 0.059 | Histone deacetylase inhibitor | 0.059 0.056 DBMET03172 | DBMET03172 | |
| 0.006 | 0.195 | 0.035 | Kainate receptor 4 antagonist | 0.035 0.011 DBMET03172 | DBMET03172 | |
| 0.01 | 0.202 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.04 0.026 DBMET03172 | DBMET03172 | |
| 0.004 | 0.199 | 0.04 | Adenosine kinase inhibitor | 0.04 0.007 DBMET03175 0.037 0.008 DBMET03176 0.02 0.016 DBMET03177 | DBMET03175 | |
| 0.012 | 0.21 | 0.044 | Prostaglandin E2 antagonist | 0.044 0.043 DBMET03173 | DBMET03173 | |
| 0.026 | 0.24 | 0.062 | Antiviral (Hepatitis D) | 0.062 0.02 DBMET03175 0.06 0.022 DBMET03176 0.053 0.031 DBMET03177 | DBMET03175 | |
| 0.013 | 0.236 | 0.043 | Nerve growth factor antagonist | 0.043 0.029 DBMET03172 | DBMET03172 | |
| 0.023 | 0.247 | 0.102 | NMDA receptor antagonist | 0.102 0.046 DBMET03174 | DBMET03174 | |
| 0.038 | 0.271 | 0.143 | Phosphodiesterase I inhibitor | 0.082 0.074 DBMET03172 0.133 0.022 DBMET03175 0.143 0.019 DBMET03176 | DBMET03176 | |
| 0.026 | 0.265 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.062 0.039 DBMET03172 | DBMET03172 | |
| 0.092 | 0.331 | 0.172 | Histone acetyltransferase inhibitor | 0.172 0.111 DBMET03172 | DBMET03172 | |
| 0.079 | 0.33 | 0.245 | 5 Hydroxytryptamine 1E antagonist | 0.245 0.08 DBMET03172 | DBMET03172 | |
| 0.008 | 0.261 | 0.037 | Melatonin 2 agonist | 0.037 0.018 DBMET03172 | DBMET03172 | |
| 0.103 | 0.361 | 0.272 | Antiobesity | 0.209 0.198 DBMET03172 0.272 0.137 DBMET03174 | DBMET03174 | |
| 0.008 | 0.267 | 0.032 | Melatonin agonist | 0.032 0.023 DBMET03172 | DBMET03172 | |
| 0.041 | 0.307 | 0.163 | Interleukin 1b antagonist | 0.111 0.069 DBMET03173 0.163 0.032 DBMET03174 | DBMET03174 | |
| 0.044 | 0.313 | 0.232 | Pyruvate kinase inhibitor | 0.232 0.067 DBMET03174 | DBMET03174 | |
| 0.004 | 0.277 | 0.02 | Kainate receptor 5 antagonist | 0.02 0.015 DBMET03172 | DBMET03172 | |
| 0.034 | 0.308 | 0.135 | Histone deacetylase class III inhibitor | 0.135 0.056 DBMET03172 | DBMET03172 | |
| 0.006 | 0.28 | 0.023 | Adenosine A3 receptor agonist | 0.023 0.007 DBMET03175 0.023 0.007 DBMET03176 0.022 0.008 DBMET03177 | DBMET03176 | |
| 0.035 | 0.313 | 0.089 | MAP kinase kinase 1 inhibitor | 0.089 0.072 DBMET03174 | DBMET03174 | |
| 0.009 | 0.304 | 0.032 | Melatonin 1 agonist | 0.032 0.025 DBMET03172 | DBMET03172 | |
| 0.044 | 0.359 | 0.121 | MAP3K9 inhibitor | 0.121 0.112 DBMET03174 | DBMET03174 | |
| 0.028 | 0.355 | 0.104 | 5 Hydroxytryptamine 3A agonist | 0.104 0.071 DBMET03172 | DBMET03172 | |
| 0.023 | 0.386 | 0.091 | Somatostatin 1 agonist | 0.091 0.04 DBMET03174 | DBMET03174 | |
| 0.12 | 0.511 | 0.313 | Calcium channel L-type activator | 0.257 0.197 DBMET03173 0.313 0.146 DBMET03174 | DBMET03174 | |
| 0.013 | 0.491 | 0.095 | Carnitine palmitoyltransferase 1B inhibitor | 0.061 0.017 DBMET03172 0.045 0.039 DBMET03173 0.046 0.035 DBMET03174 0.086 0.006 DBMET03175 0.095 0.005 DBMET03176 0.086 0.006 DBMET03177 | DBMET03176 | |
| 0.004 | 0.495 | 0.038 | Carnitine palmitoyltransferase 1A inhibitor | 0.038 0.011 DBMET03172 | DBMET03172 | |
| 0.006 | 0.527 | 0.221 | Purinergic P2 antagonist | 0.221 0.006 DBMET03175 0.216 0.006 DBMET03176 0.165 0.009 DBMET03177 | DBMET03175 | |
| 0.059 | 0.586 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 DBMET03173 0.12 0.081 DBMET03174 | DBMET03174 | |
| 0.004 | 0.54 | 0.02 | Adenosine A2b receptor agonist | 0.02 0.006 DBMET03175 0.02 0.006 DBMET03176 0.019 0.006 DBMET03177 | DBMET03176 | |
| 0.067 | 0.646 | 0.205 | MAP kinase kinase 5 inhibitor | 0.205 0.028 DBMET03173 | DBMET03173 | |
| 0.04 | 0.721 | 0.144 | Death-associated protein kinase 2 inhibitor | 0.144 0.121 DBMET03172 | DBMET03172 | |
| 0.01 | 0.758 | 0.066 | Telomerase inhibitor | 0.066 0.057 DBMET03177 | DBMET03177 | |
| 0.027 | 0.809 | 0.264 | NOS3 expression enhancer | 0.135 0.091 DBMET03172 0.264 0.024 DBMET03173 0.228 0.032 DBMET03174 | DBMET03173 | |
| 0.006 | 0.862 | 0.205 | Purinergic P2X2 antagonist | 0.205 0.004 DBMET03175 0.203 0.004 DBMET03176 0.196 0.005 DBMET03177 | DBMET03175 | |
| 0.006 | 0.866 | 0.099 | Purinergic P2Y2 antagonist | 0.099 0.004 DBMET03175 0.096 0.004 DBMET03176 0.089 0.005 DBMET03177 | DBMET03175 | |
| 0.002 | 0.897 | 0.153 | Purinergic P2Y1 antagonist | 0.153 0.002 DBMET03175 0.146 0.002 DBMET03176 0.115 0.002 DBMET03177 | DBMET03175 | |
| 0.007 | 0.941 | 0.117 | Aurora-C kinase inhibitor | 0.117 0.112 DBMET03174 | DBMET03174 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |